BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. World J Gastroenterol 2018; 24(30): 3361-3373 [PMID: 30122876 DOI: 10.3748/wjg.v24.i30.3361]
URL: https://www.wjgnet.com/1007-9327/full/v24/i30/3361.htm
Number Citing Articles
1
Ludovico Abenavoli, Luigi Boccuto, Alessandro Federico, Marcello Dallio, Carmelina Loguercio, Laura Di Renzo, Antonino De Lorenzo. Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean WayInternational Journal of Environmental Research and Public Health 2019; 16(17): 3011 doi: 10.3390/ijerph16173011
2
Sara Karjoo, Anthony Auriemma, Teresa Fraker, Harold Edward Bays. Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022Obesity Pillars 2022; 3: 100027 doi: 10.1016/j.obpill.2022.100027
3
Ridhi Deo, Suranjan Panigrahi. Explainability Analysis of Black Box SVM models for Hepatic Steatosis Screening2022 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT) 2022; : 22 doi: 10.1109/HI-POCT54491.2022.9744067
4
Chowdhury F Zaman, Jakia Sultana, Proma Dey, Jui Dutta, Sadia Mustarin, Nuzhat Tamanna, Aditi Roy, Nisha Bhowmick, Mousumi Khanam, Sadia Sultana, Selia Chowdhury, Farjana Khanam, Md Sakibuzzaman, Priyata Dutta. A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic ReviewCureus 2022;  doi: 10.7759/cureus.29657
5
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, Jin Wang. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and TreatmentInternational Journal of Molecular Sciences 2022; 23(24): 15489 doi: 10.3390/ijms232415489
6
Khara Lucius. Nutritional and Botanical Approaches for Nonalcoholic Fatty Liver DiseaseAlternative and Complementary Therapies 2020; 26(6): 246 doi: 10.1089/act.2020.29303.klu
7
Yejin Kim, Yoosoo Chang, Min-Jung Kwon, Yun Soo Hong, Mi Kyung Kim, Won Sohn, Yong Kyun Cho, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic AdultsAmerican Journal of Gastroenterology 2021; 116(11): 2270 doi: 10.14309/ajg.0000000000001344
8
Ahmed Hashem, Yogesh Shastri, Malfi Al Otaibi, Elwin Buchel, Hussam Saleh, Reyaz Ahmad, Hamouda Ahmed, Fateh Al Idris, Saleh Ahmed, Mohamed Guda, Anton Gillessen. Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of SilymarinGastroenterology Insights 2021; 12(2): 155 doi: 10.3390/gastroent12020014
9
Arshad Mehmood, Lei Zhao, Yong Wang, Fei Pan, Shuai Hao, Huimin Zhang, Asra Iftikhar, Muhammad Usman. Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive reviewFood Research International 2021; 142: 110180 doi: 10.1016/j.foodres.2021.110180
10
Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!Metabolism 2019; 101: 154001 doi: 10.1016/j.metabol.2019.154001
11
Erenie Guirguis, Yasmin Grace, Anthony Bolson, Matthew J. DellaVecchia, Melissa Ruble. Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic reviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2021; 41(3): 315 doi: 10.1002/phar.2489
12
Javier Vázquez-Bourgon, Víctor Ortiz-García de la Foz, Irene Suarez-Pereira, Paula Iruzubieta, María Teresa Arias-Loste, Esther Setién-Suero, Rosa Ayesa-Arriola, Marcos Gómez-Revuelta, Javier Crespo, Benedicto Crespo Facorro. Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosisData in Brief 2019; 27: 104415 doi: 10.1016/j.dib.2019.104415
13
Fangfei Xie, Yuyu Pei, Quan Zhou, Deli Cao, Yun Wang. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in ChinaLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01560-3
14
Chanh-Phong Tran, John J Kim, Jordan J Feld, William WL Wong. Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: An early economic evaluationCanadian Liver Journal 2021; 4(4): 360 doi: 10.3138/canlivj-2021-0011
15
Shuangzhen Jia, Yuzhen Zhao, Jiaqi Liu, Xu Guo, Moxian Chen, Shaoming Zhou, Jianli Zhou. Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic AccuracyFrontiers in Pediatrics 2022; 9 doi: 10.3389/fped.2021.784221
16
Jinyao Liu, Yumiko Oba, Seiko Yamano. Chronic ethanol consumption plus an atherogenic diet cause metabolic steatohepatitis with advanced liver fibrosis in apolipoprotein E/low‐density lipoprotein receptor double‐knockout miceAlcoholism: Clinical and Experimental Research 2022; 46(7): 1192 doi: 10.1111/acer.14852
17
Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studiesF1000Research 2023; 11: 223 doi: 10.12688/f1000research.109134.3
18
Francesco Tovoli, Silvia Ferri, Fabio Piscaglia. Hepatocellular Carcinoma in Non Alcoholic Fatty Liver DiseaseCurrent Pharmaceutical Design 2020; 26(32): 3909 doi: 10.2174/1381612826666200429093648
19
Kozue Kanemitsu-Okada, Masanori Abe, Yoshiko Nakamura, Teruki Miyake, Takao Watanabe, Osamu Yoshida, Yohei Koizumi, Masashi Hirooka, Yoshio Tokumoto, Bunzo Matsuura, Mitsuhito Koizumi, Yoichi Hiasa. Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic SteatohepatitisInternational Journal of Molecular Sciences 2023; 24(3): 2509 doi: 10.3390/ijms24032509
20
Sheng Yang, Chong Liu, Xiaowen Ji, Xuemin Chen, Yun Wang, Rong Tao. The Role of Gold Nanorods in Detecting Circulating microRNAs as Biomarkers in Liver DiseasesJournal of Biomedical Nanotechnology 2023; 19(10): 1721 doi: 10.1166/jbn.2023.3676
21
Guanghui Deng, Chang Liu, Jiamin Zhao, Ming Wang, Yunjia Li, Menghan Yang, Haixin Ye, Junjie Li, Mengchen Qin, Chaofeng Wu, Hao Shi, Yuxin Liao, Zhaoxi Zhou, Shiqing Zhang, Ken Kin Lam Yung, Lei Gao. Exocarpium Citri Grandis alleviates the aggravation of NAFLD by mitigating lipid accumulation and iron metabolism disordersJournal of Ethnopharmacology 2023; 313: 116559 doi: 10.1016/j.jep.2023.116559
22
Morteza Aghajanpoor, Mehrzad Gholampourdehaki, Reza Mosaed, Iraj Mirzaii-Dizgah, Afsaneh Vosughi. The Efficacy of Empagliflozin in Combination with Pioglitazone on the Improvement of Fatty Liver Disease in Patients with Type 2 DiabetesAnnals of Military and Health Sciences Research 2024; 22(2) doi: 10.5812/amh-144009
23
Nuojin Guo, Hekai Shi, Hao Zhang, Hua Wang. Comparison of the efficacy and safety of hypoglycemic treatments in patients with non-alcoholic fatty liver disease and type-2 diabetes: a systematic review and Bayesian network analysisEuropean Journal of Clinical Pharmacology 2023; 79(11): 1465 doi: 10.1007/s00228-023-03561-w
24
Yang Xia, Limin Cao, Qing Zhang, Li Liu, Shunming Zhang, Ge Meng, Hongmei Wu, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Adherence to a vegetable dietary pattern attenuates the risk of non‐alcoholic fatty liver disease in incident type 2 diabetes: The TCLSIH cohort studyJournal of Internal Medicine 2022; 291(4): 469 doi: 10.1111/joim.13428
25
Xiaoyan Li, Hua Wang. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver diseaseCell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00507-y
26
Ruojia Ma, Yike Zhan, Yamei Zhang, Liangan Wu, Xing Wang, Ming Guo. Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic miceDrug Development Research 2021;  doi: 10.1002/ddr.21905
27
Laya Hooshmand Gharabagh, Ali Shargh, Mohammad Reza Mohammad Hosseini Azar, Ayda Esmaeili. Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver diseaseClinics and Research in Hepatology and Gastroenterology 2024; 48(3): 102279 doi: 10.1016/j.clinre.2023.102279
28
Oh Young Kwon, Mi Kyung Lee, Hye Won Lee, Hyerang Kim, Jae Seung Lee, Yeonsoo Jang. Mobile App–Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled TrialJournal of Medical Internet Research 2024; 26: e49839 doi: 10.2196/49839
29
Inês H. Vieira, Luísa M. Barros, Carla F. Baptista, Dírcea M. Rodrigues, Isabel M. Paiva. Recommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 DiabetesClinical Diabetes 2022; 40(1): 97 doi: 10.2337/cd21-0043
30
Jörn M Schattenberg, Quentin M Anstee, Cyrielle Caussy, Elisabetta Bugianesi, Branko Popovic. Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature reviewExpert Review of Gastroenterology & Hepatology 2021; 15(11): 1253 doi: 10.1080/17474124.2021.1974295
31
Dominic S. Ng. Emerging insight into the role of cellular cholesterol in the pathogenesis of nonalcoholic steatohepatitis progressionCurrent Opinion in Lipidology 2020; 31(4): 262 doi: 10.1097/MOL.0000000000000693
32
Banshi Saboo, Sanjay Agarwal, Brij Mohan Makkar, Rajeev Chawla, Sujoy Ghosh, Vijay Viswanathan, Sunil Gupta, Ch. Vasanth Kumar, Anuj Maheshwari, L. Sreenivasamurthy, Rakesh Kumar Sahay, Sanjay Reddy, Shalini Jaggi, Jugal Kishor Sharma, Vijay Panikar, Anand Moses, Bikash Bhattacharjee, Pratap Jethwani, Sudhir Bhandari, J. P. S. Sawhney, Shashank Joshi, Saumitra Ray, S. V. Madhu, Bipin Sethi. RSSDI consensus recommendations for dyslipidemia management in diabetes mellitusInternational Journal of Diabetes in Developing Countries 2022; 42(1): 3 doi: 10.1007/s13410-022-01063-6
33
Jonathan Mertens, Christophe De Block, Maarten Spinhoven, Ann Driessen, Sven M. Francque, Wilhelmus J. Kwanten. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic HepatopathyFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.768576
34
David Brain, Amarzaya Jadambaa, Sanjeewa Kularatna. Methodology to derive preference for health screening programmes using discrete choice experiments: a scoping reviewBMC Health Services Research 2022; 22(1) doi: 10.1186/s12913-022-08464-7
35
Muhammad Radzi Abu Hassan, Rosaida Hj Md Said, Zalwani Zainuddin, Haniza Omar, Siti Maisarah Md Ali, Siti Aishah Aris, Huan-Keat Chan. Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trialHeliyon 2023; 9(6): e16652 doi: 10.1016/j.heliyon.2023.e16652
36
Yang Xia, Shunming Zhang, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Xue Bao, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Insoluble dietary fibre intake is associated with lower prevalence of newly-diagnosed non-alcoholic fatty liver disease in Chinese men: a large population-based cross-sectional studyNutrition & Metabolism 2020; 17(1) doi: 10.1186/s12986-019-0420-1
37
Rodrigo Valenzuela, Luis A. Videla. Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic ViewNutrients 2020; 12(2): 499 doi: 10.3390/nu12020499
38
Yuling Song, Boru Chen, Lu Jiang, Fangkun Zhao, Xiuqin Feng. Global Trends of Treatment for NAFLD from 2012 to 2021: A Bibliometric and Mapping AnalysisEndocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24(5): 573 doi: 10.2174/0118715303230418230925060312
39
Harold E. Bays, Amit Khera, Michael J. Blaha, Matthew J Budoff, Peter P. Toth. Ten things to know about ten imaging studies: A preventive cardiology perspective (“ASPC top ten imaging”)American Journal of Preventive Cardiology 2021; 6: 100176 doi: 10.1016/j.ajpc.2021.100176
40
Natalia O. Nosko, Viacheslav V. Kharchenko. INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASEWiadomości Lekarskie 2021; 74(10): 2593 doi: 10.36740/WLek202110212
41
Zhixin Zhang, Jiahui Wang, Yan Lin, Juan Chen, Jian Liu, Xian Zhang. Nutritional activities of luteolin in obesity and associated metabolic diseases: an eye on adipose tissuesCritical Reviews in Food Science and Nutrition 2024; 64(12): 4016 doi: 10.1080/10408398.2022.2138257
42
Anne M. Misher, Jennifer L. Rosselli, Christine A. Schumacher, Michael See. The Role of the Diabetes Care and Education Specialist in Caring for Diabetes Complications and Common Comorbid ConditionsADCES in Practice 2021; 9(3): 30 doi: 10.1177/2633559X211002805
43
Josephine Skat-Rørdam, Kamilla Pedersen, Gry Freja Skovsted, Ida Gregersen, Sara Vangsgaard, David H. Ipsen, Markus Latta, Jens Lykkesfeldt, Pernille Tveden-Nyborg. Vitamin C Deficiency May Delay Diet-Induced NASH Regression in the Guinea PigAntioxidants 2021; 11(1): 69 doi: 10.3390/antiox11010069
44
Annamaria Sila, Sara De Nucci, Caterina Bonfiglio, Vincenza Di Stasi, Nicole Cerabino, Martina Di Chito, Roberta Rinaldi, Paola Cantalice, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Nicoletta Maria Tutino, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and ObesityNutrients 2024; 16(6): 874 doi: 10.3390/nu16060874
45
Zeinab El Rashed, Elena Grasselli, Hala Khalifeh, Laura Canesi, Ilaria Demori. Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver DiseasePlanta Medica 2022; 88(01): 9 doi: 10.1055/a-1273-3159
46
Галина Корнован , Володимир Синенко , Лариса Колотвіна , Яна Бажора , Дарʼя Лагода , Вероніка Назарян , Ганна Амірова , Олена Паслар . КОМОРБІДНА ПАТОЛОГІЯ ПЕЧІНКИ У ПАЦІЄНТІВ, ЯКІ ЖИВУТЬ З ОЖИРІННЯМGrail of Science 2022; (17): 419 doi: 10.36074/grail-of-science.22.07.2022.073
47
Kenny Mendoza, Víctor Eduardo Villalobos-Daniel, Alejandra Jáuregui, Isabel Valero-Morales, César Hernández-Alcaraz, Nelson Zacarías-Alejandro, Ricardo Omar Alarcon-Guevara, Simón Barquera. Development of a crowdsourcing- and gamification-based mobile application to collect epidemiological information and promote healthy lifestyles in MexicoScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56761-4
48
Fangzhi Yue, Ying Shi, Shanyu Wu, Lin Xing, Dan He, Lin Wei, Anqi Qiu, Ryan Russell, Dongmei Zhang. Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLDiScience 2023; 26(12): 108560 doi: 10.1016/j.isci.2023.108560
49
Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studiesF1000Research 2022; 11: 223 doi: 10.12688/f1000research.109134.1
50
Rui Tavares, Mireia Alemany-Pagès, Sara Araújo, Neil Cohn, João Ramalho-Santos, Anabela Marisa Azul. Comics in Science and Health Communication: Insights From Mutual Collaboration and Framing a Research PracticeInternational Journal of Qualitative Methods 2023; 22 doi: 10.1177/16094069231183118
51
Martin M. Grajower. Nonalcoholic SteatohepatitisJAMA 2020; 324(9): 899 doi: 10.1001/jama.2020.10434
52
Marco Arrese, Francisco Barrera, Nicolas Triantafilo, Juan Pablo Arab. Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerationsExpert Review of Gastroenterology & Hepatology 2019; 13(9): 849 doi: 10.1080/17474124.2019.1649981
53
T. N. Alexandrova, O. Ya. Babak . Effects of Ademetionine on Liver Fibrosis, Level of Pentraxin-3 and Metabolic Indicators in Patients with Comorbid Course of Non-alcoholic Liver Disease and Arterial HypertensionUkraïnsʹkij žurnal medicini, bìologìï ta sportu 2020; 5(6): 95 doi: 10.26693/jmbs05.06.095
54
Somaya Albhaisi. Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?EMJ Hepatology 2019; : 80 doi: 10.33590/emjhepatol/10311541
55
Chayanis Kositamongkol, Sukrit Kanchanasurakit, Chiraphong Auttamalang, Nutkamon Inchai, Thanatchaporn Kabkaew, Sarunporn Kitpark, Nathorn Chaiyakunapruk, Acharaporn Duangjai, Surasak Saokaew, Pochamana Phisalprapa. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysisFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.786596
56
Luis Vega, Daniela Simian, Abraham I. Gajardo, Marcelo Salinas, Andrea Urra, Máximo Cattaneo, Rosario Pino, Juan P. Roblero, Álvaro Urzúa, Katherine Rojas, Jaime Poniachik. Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosisAnnals of Hepatology 2024; : 101511 doi: 10.1016/j.aohep.2024.101511
57
David Hermanus Wessels, Zeil Rosenberg. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?World Journal of Hepatology 2021; 13(2): 233-241 doi: 10.4254/wjh.v13.i2.233
58
Sina Ghandian, Rahul Thapa, Anurag Garikipati, Gina Barnes, Abigail Green‐Saxena, Jacob Calvert, Qingqing Mao, Ritankar Das. Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosisJGH Open 2022; 6(3): 196 doi: 10.1002/jgh3.12716
59
Leilei Yu, Ruohan Zhao, Chen Wang, Chengcheng Zhang, Chuanqi Chu, Jianxin Zhao, Hao Zhang, Qixiao Zhai, Wei Chen, Heng Zhang, Fengwei Tian. Effects of garlic supplementation on non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trialsJournal of Functional Foods 2022; 99: 105294 doi: 10.1016/j.jff.2022.105294
60
Rachelle Haber, Fatima Zarzour, Malak Ghezzawi, Natalie Saadeh, Dania S. Bacha, Lama Al Jebbawi, Marlene Chakhtoura, Christos S. Mantzoros. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trialsDiabetes, Obesity and Metabolism 2024; 26(5): 1850 doi: 10.1111/dom.15501
61
Yi Dong, Wen-Ping Wang, Won Jae Lee, Maria Franca Meloni, Dirk-Andre Clevert, Maria Cristina Chammas, Andrea Tannapfel, Antonella Forgione, Fabio Piscaglia, Christoph Frank Dietrich. Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter StudyUltrasound in Medicine & Biology 2022; 48(9): 1797 doi: 10.1016/j.ultrasmedbio.2022.05.005
62
Yang Xia, Qijun Wu, Huixu Dai, Jiale Lv, Yashu Liu, Hui Sun, Yuting Jiang, Qing Chang, Kaijun Niu, Yuhong Zhao. Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 ParticipantsFrontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.642509
63
Manouchehr Khoshbaten, Samineh Beheshtirouy, Shahrzad Shayanrad, Afshin Gharekhani, Haleh Rezaee. Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trialDrug Research 2023; 73(04): 232 doi: 10.1055/a-1997-0401
64
Kamil Synoradzki, Paweł Grieb. Citicoline: A Superior Form of Choline?Nutrients 2019; 11(7): 1569 doi: 10.3390/nu11071569
65
Zhuo Wei, Dan Zhao, Ye Zhang, Yuanli Chen, Shuang Zhang, Qi Li, Peng Zeng, Xiaoju Li, Wenwen Zhang, Yajun Duan, Jihong Han, Xiaoxiao Yang. Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent mannerBiochemical and Biophysical Research Communications 2019; 519(4): 854 doi: 10.1016/j.bbrc.2019.09.084
66
Sahar H. Elhini, Engy A. Wahsh, Ahmed A. Elberry, Nadia F. El Ameen, Ahmed Abdelfadil Saedii, Shereen Mahmoud Refaie, Asmaa A. Elsayed, Hoda M. Rabea. The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic PatientsPharmaceuticals 2022; 15(12): 1516 doi: 10.3390/ph15121516
67
Stephan C. Bischoff, Johann Ockenga, Ahad Eshraghian, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guidelineClinical Nutrition 2023; 42(6): 987 doi: 10.1016/j.clnu.2023.03.021
68
Jae-Hyung Roh, Hanbyul Lee, Bae Yun-Jeong, Chan Sun Park, Hyo-Jung Kim, Sun-Young Yoon, Huei-Kai Huang. A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adultsPLOS ONE 2022; 17(1): e0262715 doi: 10.1371/journal.pone.0262715
69
Joana Rigor, Andreia Diegues, José Presa, Pedro Barata, Daniela Martins-Mendes. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese populationPostgraduate Medicine 2022; 134(4): 435 doi: 10.1080/00325481.2022.2058285
70
Somaya Albhaisi. Noninvasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?European Medical Journal 2019; : 57 doi: 10.33590/emj/10310531
71
Hideyuki Tamai, Jumpei Okamura, Kishio Nanjo. Moderate‐carbohydrate diet without caloric or lipid restriction for Japanese adult patients with nonalcoholic fatty liver disease: A prospective cohort studyHepatology Research 2023; 53(12): 1185 doi: 10.1111/hepr.13954
72
Mahboobe Hosseinikia, Farhad Oubari, Roghaye Hosseinkia, Zibaneh Tabeshfar, Mohammad Gharib Salehi, Zeinab Mousavian, Mehrnaz Abbasi, Mehnoosh Samadi, Yahya Pasdar. Quercetin supplementation in non-alcoholic fatty liver diseaseNutrition & Food Science 2020; 50(6): 1279 doi: 10.1108/NFS-10-2019-0321
73
Abeer Abdel-latif, Ula Mabid Al-Jarhi, Dina Hesham, Mona khozam, Shaimaa A. Fathy. Sex hormone binding globulin (SHBG) as a predictor of liver fibrosis in subjects with nonalcoholic fatty liver disease (NAFLD)The Egyptian Journal of Internal Medicine 2023; 35(1) doi: 10.1186/s43162-023-00220-5
74
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangementAlimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
75
Di Cao, Mengyi Li, Yang Liu, He Jin, Dawei Yang, Hui Xu, Han Lv, JIa Liu, Peng Zhang, Zhongtao Zhang, Zhenghan Yang. Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional studyBMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00821-6
76
Cai-yan Zou, Yan Sun, Jun Liang. Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,Clinics and Research in Hepatology and Gastroenterology 2023; 47(1): 102053 doi: 10.1016/j.clinre.2022.102053
77
Dóra Mátis, Péter Hegyi, Brigitta Teutsch, Tamás Tornai, Bálint Erőss, Gabriella Pár, Szilárd Váncsa. Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studiesFrontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1114836
78
Bitasta Mandal, Rakesh Das, Sandip Mondal. Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver diseaseAnnales Pharmaceutiques Françaises 2024; 82(3): 373 doi: 10.1016/j.pharma.2024.02.005
79
Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and AdolescentsFrontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.667247
80
John A. Dougherty, Erenie Guirguis, Krisy-Ann Thornby. A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver DiseaseAnnals of Pharmacotherapy 2021; 55(1): 65 doi: 10.1177/1060028020935105
81
Feryal Savari, Seyed Ali Mard. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatmentHeliyon 2024; 10(7): e28468 doi: 10.1016/j.heliyon.2024.e28468
82
Mary P. Moore, Rory P. Cunningham, Rachel A. H. Davis, Sarah E. Deemer, Brandon M. Roberts, Eric P. Plaisance, R. Scott Rector. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(4): G564 doi: 10.1152/ajpgi.00259.2020
83
Kamlesh K. Bhopale, Mukund P. Srinivasan. Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)Livers 2023; 3(4): 597 doi: 10.3390/livers3040040
84
M. Zhang, W.J. Tu, Q. Zhang, X.L. Wu, X.Y. Zou, S. Jiang. Osteocalcin reduces fat accumulation and inflammatory reaction by inhibiting ROS-JNK signal pathway in chicken embryonic hepatocytesPoultry Science 2022; 101(11): 102026 doi: 10.1016/j.psj.2022.102026
85
Wen Fan, Kairui Tang, Yuanjun Deng, Chuiyang Zheng, Maoxing Pan, Dajin Pi, Zheng Liang, Jianwei Zhen, Qinhe Yang, Yupei Zhang. Bifidobacterium lactis Probio‐M8 prevents nonalcoholic fatty liver disease in high‐fat diet‐fed rats: The potential role in modulating gut microbiotaFood Bioengineering 2024; 3(1): 29 doi: 10.1002/fbe2.12076
86
Zhaowei Dong, Jingjing Yang, Maoying Tian, Xi Wang, Xiaoyan Qin, Qinwan Huang, Jin Wang. Mechanism of Bile‐Processed Coptidis Rhizoma to Treat Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Based on UPLC‐Q‐TOF/MS and Network PharmacologyChemistrySelect 2023; 8(13) doi: 10.1002/slct.202204236
87
Jennifer Linge, Patrik Nasr, Arun J. Sanyal, Olof Dahlqvist Leinhard, Mattias Ekstedt. Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLDJHEP Reports 2023; 5(3): 100663 doi: 10.1016/j.jhepr.2022.100663
88
Jinyun Li, Lu Fang, Miaocui Xi, Anyu Ni, Qiuhui Qian, Zejun Wang, Huili Wang, Jin Yan. Toxic effects of triclosan on hepatic and intestinal lipid accumulation in zebrafish via regulation of m6A-RNA methylationAquatic Toxicology 2024; 269: 106884 doi: 10.1016/j.aquatox.2024.106884
89
Nonalcoholic Steatohepatitis: Case-Based Focused on Pediatric and Adult GuidelinesOsteopathic Family Physician 2021; 13(2): 29 doi: 10.33181/13024
90
Lu Zhong, Xiaojuan Peng, Chutian Wu, Qing Li, Yanfang Chen, Min Wang, Yuting Li, Kaiyin He, Ying Shi, Caiqun Bie, Shaohui Tang. Polysaccharides and flavonoids from cyclocarya paliurus modulate gut microbiota and attenuate hepatic steatosis, hyperglycemia, and hyperlipidemia in nonalcoholic fatty liver disease rats with type 2 diabetes mellitusInternational Journal of Diabetes in Developing Countries 2023; 43(2): 317 doi: 10.1007/s13410-022-01080-5
91
Maximilian J. Ganz, Sascha T. Bender, Christian Gross, Katrin Bose, Peter R. Mertens, Florian G. Scurt. Metabolisches Syndrom und NierenkrankheitenDie Nephrologie 2022; 17(5): 291 doi: 10.1007/s11560-022-00595-6
92
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, Marlene Chakhtoura, Michael A. Hill, Dimitri P. Mikhailidis, Christos S. Mantzoros, Ali Eid. Steatotic Liver Disease: Pathophysiology and Emerging PharmacotherapiesPharmacological Reviews 2024; 76(3): 454 doi: 10.1124/pharmrev.123.001087
93
Yiwei Ma, Xinyue Ding, Jie Gu, Shengmin Zhou, Yuanrong Jiang. Effects of olive oil on hepatic steatosis and liver enzymes: A systematic reviewJournal of Functional Foods 2023; 109: 105815 doi: 10.1016/j.jff.2023.105815
94
Amedeo Lonardo, Stefano Ballestri. Perspectives of nonalcoholic fatty liver disease research: a personal point of viewExploration of Medicine 2020; 1(3): 85 doi: 10.37349/emed.2020.00007
95
Yuichiro Eguchi, Gabriel Wong, Omar Akhtar, Yoshio Sumida. Non‐invasive diagnosis of non‐alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature reviewHepatology Research 2020; 50(6): 645 doi: 10.1111/hepr.13502
96
Karolina Grąt, Michał Grąt, Olgierd Rowiński. Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver DiseaseBiomedicines 2020; 8(9): 298 doi: 10.3390/biomedicines8090298
97
Implementing the Mediterranean Diet2022; : 234 doi: 10.1002/9781119826743.ch13
98
Peyda Korhan, Ezgi Bağırsakçı, Yasemin Öztemur Islakoğlu, Gülhas Solmaz, Burcu Sarıkaya, Deniz Nart, Funda Yılmaz, Neşe Atabey. MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinomaHepatoma Research 2024;  doi: 10.20517/2394-5079.2023.140
99
Eric R. Yoo, Donghee Kim, Luis M. Vazquez‐Montesino, Jessica A. Escober, Andrew A. Li, Sean P. Tighe, Christopher T. Fernandes, George Cholankeril, Aijaz Ahmed. Diet quality and its association with nonalcoholic fatty liver disease and all‐cause and cause‐specific mortalityLiver International 2020; 40(4): 815 doi: 10.1111/liv.14374
100
Kim Sui Wan, Halizah Mat Rifin, Muhammad Fadhli Mohd Yusoff, Kishwen Kanna Yoga Ratnam, Wah Kheong Chan, Masni Mohamad, Nurain Mohd Noor, Feisul Mustapha, Noor Ani Ahmad. Prevalence of metabolic syndrome and metabolic dysfunction-associated fatty liver disease in Malaysia 2023: study protocol for a community-based nationwide cross-sectional surveyBMJ Open 2023; 13(10): e074432 doi: 10.1136/bmjopen-2023-074432
101
Chiara Zusi, Alessandro Mantovani, Francesca Olivieri, Anita Morandi, Massimiliano Corradi, Emanuele Miraglia Del Giudice, Marco Dauriz, Luca Valenti, Christopher D. Byrne, Giovanni Targher, Claudio Maffeis. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescentsDigestive and Liver Disease 2019; 51(11): 1586 doi: 10.1016/j.dld.2019.05.029
102
Alessia De Masi, Xiaoxu Li, Dohyun Lee, Jongsu Jeon, Qi Wang, Seoyeong Baek, Onyu Park, Adrienne Mottis, Keno Strotjohann, Alexis Rapin, Hoe-Yune Jung, Johan Auwerx. Cyclo(His-Pro): A further step in the management of steatohepatitisJHEP Reports 2023; 5(9): 100815 doi: 10.1016/j.jhepr.2023.100815
103
Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A. A. Abdel‐Ghany, Mohamed O. Mahmoud. Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathwayArchiv der Pharmazie 2024; 357(4) doi: 10.1002/ardp.202300631
104
Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel, Victoria Villena. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approachWorld Journal of Gastroenterology 2021; 27(41): 7113-7124 doi: 10.3748/wjg.v27.i41.7113
105
Tongxi Zhuang, Wei Li, Li Yang, Zhengtao Wang, Lili Ding, Mingmei Zhou. Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its ComplicationsFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.731288
106
Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad. History of Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2020; 21(16): 5888 doi: 10.3390/ijms21165888
107
Dóra Mátis, Brigitta Teutsch, Szilárd Váncsa. Improved body composition is associated with reduced steatosis in non-alcoholic fatty liver disease, a systematic review and meta-analysis of longitudinal studiesBulletin of Medical Sciences 2022; 95(1): 89 doi: 10.2478/orvtudert-2022-0006
108
Fangfei Xie, Hong Zhou, Yun Wang. Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han populationLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1112-6
109
J.M. Carrascosa, E. Vilarrasa, I. Belinchón, P. Herranz, J. Crespo, F. Guimerá, A. Olveira. [Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of ExpertsActas Dermo-Sifiliográficas 2023; 114(5): T392 doi: 10.1016/j.ad.2023.04.013
110
Da Hyun Lee, Jai J. Jee, Yu Seol Lee, Da Ye Kim, Ji Yun Bang, Hye Won Lee, Hong Koh, Soo Han Bae. Fecal microbiota transplantation improves hepatic fibro-inflammation via regulating oxidative stress in experimental NASHDigestive and Liver Disease 2023; 55(11): 1521 doi: 10.1016/j.dld.2023.06.015
111
Stefano Ciardullo, Tommaso Monti, Gianluca Perseghin. Lack of awareness of liver organ damage in patients with type 2 diabetesActa Diabetologica 2021; 58(5): 651 doi: 10.1007/s00592-021-01677-y
112
David J. Hanna, Scott T. Jamieson, Christine S. Lee, Christopher A. Pluskota, Nicole J. Bressler, Peter N. Benotti, Sandeep Khurana, David D. K. Rolston, Christopher D. Still. “Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”Obesity Science & Practice 2021; 7(5): 629 doi: 10.1002/osp4.509
113
Alessio Aghemo, Olga P. Alekseeva, Francesco Angelico, Igor G. Bakulin, Natalia V. Bakulina, Dmitry Bordin, Alexey O. Bueverov, Oxana M. Drapkina, Anton Gillessen, Elvira M. Kagarmanova, Natalia V. Korochanskaya, U. A. Kucheryavii, Leonid B. Lazebnik, Maria A. Livzan, Igor V. Maev, Anatolii I. Martynov, Marina F. Osipenko, Evgenii I. Sas, Antonina Starodubova, Yurii P. Uspensky, Elena V. Vinnitskaya, Emilia P. Yakovenko, Alexey A. Yakovlev. Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative reviewAnnals of Medicine 2022; 54(1): 1548 doi: 10.1080/07853890.2022.2069854
114
Yu Zhu, Hu Yang, Shaoxian Liang, Honghua Zhang, Yufeng Mo, Songxian Rao, Yaozong Zhang, Zhuang Zhang, Weiqiang Wang, Wanshui Yang. Higher Adherence to Healthy Lifestyle Score Is Associated with Lower Odds of Non-Alcoholic Fatty Liver DiseaseNutrients 2022; 14(21): 4462 doi: 10.3390/nu14214462
115
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver diseaseMedicina Clínica (English Edition) 2022; 158(11): 550 doi: 10.1016/j.medcle.2022.05.009
116
Minal Patel. Evidence-based management of patients with nonalcoholic fatty liver diseaseJAAPA 2022; 35(8): 20 doi: 10.1097/01.JAA.0000840492.53680.59
117
Lvying Wu, Lei Xing, Yake Zou, Zichen Wang, Yuanyuan Gou, Lei Zhang, Su Guan. UPLC-QTOF-MS Based Comparison of Rotundic Acid Metabolic Profiles in Normal and NAFLD RatsMetabolites 2022; 13(1): 38 doi: 10.3390/metabo13010038
118
Guanghui Deng, Junjie Li, Manping Huang, Yunjia Li, Hao Shi, Chaofeng Wu, Jiamin Zhao, Mengchen Qin, Chang Liu, Menghan Yang, Yunqing Wang, Yuxue Zhang, Yuxin Liao, Chuying Zhou, Jian Yang, Yunsheng Xu, Bin Liu, Lei Gao. Erchen decoction alleviates the progression of NAFLD by inhibiting lipid accumulation and iron overload through Caveolin-1 signalingJournal of Ethnopharmacology 2024; 319: 117320 doi: 10.1016/j.jep.2023.117320
119
Jean-François Dufour, Roger Scherer, Maria-Magdalena Balp, Sarah Jane McKenna, Nico Janssens, Patricia Lopez, Marcos Pedrosa. The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature reviewEndocrine and Metabolic Science 2021; 3: 100089 doi: 10.1016/j.endmts.2021.100089
120
Stavroula Zagkou, Valentine Marais, Narimane Zeghoudi, Edouard Le Guillou, Eeva-Liisa Eskelinen, Ganna Panasyuk, Bernard Verrier, Charlotte Primard. Design and Evaluation of Autophagy-Inducing Particles for the Treatment of Abnormal Lipid AccumulationPharmaceutics 2022; 14(7): 1379 doi: 10.3390/pharmaceutics14071379
121
Alberto Enrico Maraolo, Antonio Riccardo Buonomo, Emanuela Zappulo, Riccardo Scotto, Biagio Pinchera, Ivan Gentile. Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of FungiReviews on Recent Clinical Trials 2019; 14(2): 129 doi: 10.2174/1574887114666181204102516
122
Xin Tang, Yongkang Zhou, Fei Liu, Botao Wang, Bingyong Mao, Qiuxiang Zhang, Jianxin Zhao, Wei Chen, Shumao Cui. A Pueraria lobata root extract alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating the gut microbiota and associated metabolitesFood Bioscience 2024; 59: 103746 doi: 10.1016/j.fbio.2024.103746
123
Yuxiu Liu, Shiying Liu, Jiaofeng Huang, Yueyong Zhu, Su Lin. Validation of five hepatic steatosis algorithms in metabolic‐associated fatty liver disease: A population based studyJournal of Gastroenterology and Hepatology 2022; 37(5): 938 doi: 10.1111/jgh.15799
124
Yurou Xu, Youyi Wang, Qi Zhao, Bo Chen, Na Wang, Tiejun Zhang, Yonggen Jiang, Yiling Wu, Na He, Genming Zhao, Xing Liu. Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese populationHepatology International 2024; 18(2): 529 doi: 10.1007/s12072-024-10638-w
125
Vahid Sheikhi, Zahra Heidari. Association of subclinical hypothyroidism with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A cross-sectional studyAdvanced Biomedical Research 2022; 11(1): 124 doi: 10.4103/abr.abr_15_21
126
Tsung-Hsien Chou, Hsing-Jung Yeh, Chun-Chao Chang, Jui-Hsiang Tang, Wei-Yu Kao, I-Chia Su, Chien-Hung Li, Wei-Hao Chang, Chun-Kai Huang, Herdiantri Sufriyana, Emily Chia-Yu Su. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liverJournal of the Chinese Medical Association 2021; 84(9): 842 doi: 10.1097/JCMA.0000000000000585
127
Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, Juan Pablo Arab, Rachel L. Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M. Ashworth Dirac, Sven Francque, Jacob George, Hannes Hagström, Terry T.-K. Huang, Mona H. Ismail, Achim Kautz, Shiv Kumar Sarin, Rohit Loomba, Veronica Miller, Philip N. Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary Rinella, Diana Romero, Manuel Romero-Gómez, Jörn M. Schattenberg, Emmanuel A. Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M. Younossi, Shira Zelber-Sagi, Fredrik Åberg, Leon Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M. Allen, Faisal Alnaser, Saleh A. Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J. Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramon Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourliere, Radan Bruha, Elisabetta Bugianesi, Patrizia Burra, Maria Buti, Christopher D. Byrne, Jose Luis Calleja, Patrizia Carrieri, Flloyd Carter, Marlen Ivon Castellanos Fernandez, Gabriela Castillo-Lopez, Graciela E. Castro-Narro, Henry Lik Yuen Chan, Wah-Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J. Coppell, Kathleen Corey, Antonio Craxi, Donna Cryer, Anuradha Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Ledinghen, Stefano DelPrato, Alessandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El Kassas, Osama M. Elsanousi, Gamal Esmat, Jian-Gao Fan, Nathalie Farpour-Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino A. Gani, Lynn Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon-Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch, Ingrid J. Hickman, Samantha L. Hocking, Bela Hunyady, Ramazan Idilman, Vasily A. Isakov, Mohammad H. Jamal, Peter Jepsen, Natacha Jreige Iskandar, Myeong Jun Song, K. C. Sudhamshu, Satoru Kakizaki, George Kalamitsis, Fasiha Kanwal, Jia-Horng Kao, Lee Kaplan, Takumi Kawaguchi, Yousef Khader, Seung Up Kim, Nicolas Kodjoh, Ger Koek, Kazuhiko Koike, Narcisse Patrice Komas, Marko Korenjak, Marcelo Kugelmas, Asma Labidi, Naomi F. Lange, Joel E. Lavine, Mariana Lazo, Nancy Lee, Cosmas Rinaldi A. Lesmana, Chun-Jen Liu, Michelle T. Long, Patricio Lopez-Jaramillo, Reza Malekzadeh, Mamun Al Mahtab, Giulio Marchesini, Rui Marinho, Sophia E. Martínez Vázquez, Lyudmila Mateva, Charles Mbendi Nlombi, Pascal Melin, Ivana Mikolasevic, Tamara Milovanovic, Carla Musso, Atsushi Nakajima, Edna Nava, Alexander V. Nersesov, Dafina Nikolova, Suzanne Norris, Katja Novak, Jude Oben, Janus P. Ong, Charles Onyekwere, George Papatheodoridis, Imran Paruk, Keyur Patel, M. Paula Macedo, Carlos Penha-Gonçalves, Marlene Pérez Figueroa, Wolf Peter Hofmann, Salvatore Petta, Claudia Pinto Marques Souza de Oliveira, Puneet Puri, Calvin Q. Pan, Marek Rac, Johanna Ralston, Alnoor Ramji, Homie Razavi, Mario Reis Alvares-da-Silva, Stuart Roberts, Michael Roden, Tamsin Rose, Samir Rouabhia, Patrizia Rovere-Querini, Ian A. Rowe, Shakhlo Sadirova, Riina Salupere, Tobokalova Saparbu, Raymond Sayegh, Giada Sebastiani, Yosuke Seki, Josefina Selmo, Abdel Karim Serme, Jonathan E. Shaw, Thrivikrama Shenoy, Nick Sheron, Oren Shibolet, Marcelo Silva, Igor Skrypnyk, Piotr Socha, Joan Soriano, C. Wendy Spearman, Kannan Sridharan, Juan José Suárez, Dhastagir Sultan Sheriff, Ki-Chul Sung, Mark Swain, Frank Tacke, Shahrad Taheri, Soek-Siam Tan, Elliot B. Tapper, Hannele Yki-Järvinen, Maja Thiele, Isaac Thom Shawa, Ieva Tolmane, Esther A. Torres, Michael Trauner, Sombat Treeprasertsuk, Adela Turcanu, Jonas Valantinas, Mette Vesterhus, Imam Waked, Sarah H. Wild, Jose Willemse, Robert J. Wong, Stavra Xanthakos, Dan Yock Young, Ming-Lung Yu, Kenneth I. Zheng, Mudjat Zeybel, Ming-Hua Zheng. Advancing the global public health agenda for NAFLD: a consensus statementNature Reviews Gastroenterology & Hepatology 2022; 19(1): 60 doi: 10.1038/s41575-021-00523-4
128
Ewa Garbiec, Judyta Cielecka-Piontek, Magdalena Kowalówka, Magdalena Hołubiec, Przemysław Zalewski. Genistein—Opportunities Related to an Interesting Molecule of Natural OriginMolecules 2022; 27(3): 815 doi: 10.3390/molecules27030815
129
Halyna Kuznietsova, Oksana Lynchak, Natalia Dziubenko, Tetyana Herheliuk, Yuriy Prylutskyy, Volodymyr Rybalchenko, Uwe Ritter. Water-soluble pristine C60 fullerene attenuates acetaminophen-induced liver injuryBioImpacts 2019; 9(4): 227 doi: 10.15171/bi.2019.28
130
Sara De Nucci, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Martina Di Chito, Roberta Rinaldi, Vito Giannuzzi, Raffaele Cozzolongo, Giuseppina Piazzolla, Gianluigi Giannelli, Rodolfo Sardone, Giovanni De Pergola. Associations between serum biomarkers and non-alcoholic liver disease: Results of a clinical study of Mediterranean patients with obesityFrontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1002669
131
Ting-Yu Chen, Ya-Ling Chen, Wan-Chun Chiu, Chiu-Li Yeh, Yu-Tang Tung, Hitoshi Shirakawa, Wei-Tzu Liao, Suh-Ching Yang. Effects of the Water Extract of Fermented Rice Bran on Liver Damage and Intestinal Injury in Aged Rats with High-Fat Diet FeedingPlants 2022; 11(5): 607 doi: 10.3390/plants11050607
132
Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studiesF1000Research 2023; 11: 223 doi: 10.12688/f1000research.109134.2
133
Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?Nutrients 2019; 11(12): 2878 doi: 10.3390/nu11122878
134
Rebecca Sewter, Susan Heaney, Amanda Patterson. Coffee Consumption and the Progression of NAFLD: A Systematic ReviewNutrients 2021; 13(7): 2381 doi: 10.3390/nu13072381
135
Mélanie Maltais, Diane Brisson, Daniel Gaudet. Non-Alcoholic Fatty Liver in Patients with ChylomicronemiaJournal of Clinical Medicine 2021; 10(4): 669 doi: 10.3390/jcm10040669
136
Suranjan Panigrahi, Ridhi Deo, Edward A. Liechty. A New Machine Learning-Based Complementary Approach for Screening of NAFLD (Hepatic Steatosis)2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2021; : 2343 doi: 10.1109/EMBC46164.2021.9629507
137
Hannah Drescher, Sabine Weiskirchen, Ralf Weiskirchen. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)Cells 2019; 8(8): 845 doi: 10.3390/cells8080845
138
Patrick T. Campbell, Lisa B. VanWagner, Laura A. Colangelo, Cora E. Lewis, Anne Henkel, Veeral H. Ajmera, Donald M. Lloyd‐Jones, Douglas E. Vaughan, Sadiya S. Khan. Association between plasminogen activator inhibitor‐1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIALiver International 2020; 40(5): 1111 doi: 10.1111/liv.14417
139
Zoran Gluvic, Ratko Tomasevic, Ksenija Bojovic, Milan Obradovic, Esma R. Isenovic. Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach—the institutional adaptation to existing Clinical Practice GuidelinesEmergency and Critical Care Medicine 2022; 2(1): 12 doi: 10.1097/EC9.0000000000000016
140
Amélio F. Godoy-Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, João Marcello de Araujo-Neto, Marcello Casaccia Bertoluci. 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetesDiabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01259-2
141
Renata Risi, Rossella Tozzi, Mikiko Watanabe. Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restrictionCurrent Opinion in Clinical Nutrition & Metabolic Care 2021; 24(4): 349 doi: 10.1097/MCO.0000000000000762
142
Non-Neoplastic Diseases of the Liver2022; : 265 doi: 10.55418/9781933477183-9
143
Joshua Tseng, Jeremy Korman, Mazen Noureddin, Daniel Shouhed, James P. Miller, Xiaoxi Feng, Miguel Burch. Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASHObesity Surgery 2022; 32(2): 463 doi: 10.1007/s11695-021-05797-w
144
Dieter Furthner, Daniel Weghuber, Christopher Dalus, Andreas Lukas, Hannah N. Stundner-Ladenhauf, Harald Mangge, Thomas Pixner. Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research GapsHormone Research in Paediatrics 2022; 95(2): 167 doi: 10.1159/000518595
145
Muhammad Masroor, Zeba Haque. HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric ParametersJournal of Clinical and Translational Hepatology 2021; 0(000): 1 doi: 10.14218/JCTH.2019.00046
146
Sandra A. Soto‐Alarcón, Macarena Ortiz, Paula Orellana, Francisca Echeverría, Andrés Bustamante, Alejandra Espinosa, Paola Illesca, Daniel Gonzalez‐Mañán, Rodrigo Valenzuela, Luis A. Videla. Docosahexaenoic acid and hydroxytyrosol co‐administration fully prevents liver steatosis and related parameters in mice subjected to high‐fat diet: A molecular approachBioFactors 2019; 45(6): 930 doi: 10.1002/biof.1556
147
Rodrigo M Carrillo-Larco, Wilmer Cristobal Guzman-Vilca, Manuel Castillo-Cara, Claudia Alvizuri-Gómez, Saleh Alqahtani, Vanessa Garcia-Larsen. Phenotypes of non-alcoholic fatty liver disease (NAFLD) and all-cause mortality: unsupervised machine learning analysis of NHANES IIIBMJ Open 2022; 12(11): e067203 doi: 10.1136/bmjopen-2022-067203
148
Abdulrahman Ismaiel, Stefan-Lucian Popa, Dan L. Dumitrascu, Quirino Lai. Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: “Un Affaire de Coeur”Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8825615
149
Stergios A. Polyzos, Dimitrios G. Goulis, Olga Giouleme, Georgios S. Germanidis, Antonis Goulas. Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver DiseaseCurrent Obesity Reports 2022; 11(3): 166 doi: 10.1007/s13679-022-00474-0
150
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver diseaseMedicina Clínica 2022; 158(11): 550 doi: 10.1016/j.medcli.2021.12.003
151
RehabF Abdel-Rahman. Non-alcoholic fatty liver disease: Epidemiology, pathophysiology and an update on the therapeutic approachesAsian Pacific Journal of Tropical Biomedicine 2022; 12(3): 99 doi: 10.4103/2221-1691.338919
152
Renate L. Hall, Elena S. George, Audrey C. Tierney, Anjana J. Reddy. Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisAdvances in Nutrition 2023; 14(3): 475 doi: 10.1016/j.advnut.2023.01.001
153
Preethi Chandrasekaran, Ralf Weiskirchen. The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic SteatosisInternational Journal of Molecular Sciences 2024; 25(2): 1109 doi: 10.3390/ijms25021109
154
Ricard Corcelles, Juan S. Barajas-Gamboa, Joana Ferrer-Fàbrega, Matthew Kroh. Cirugía bariátrica en trasplante hepático: tendencias actuales y perspectivas futurasCirugía Española 2022; 100(2): 59 doi: 10.1016/j.ciresp.2021.04.025
155
Ricard Corcelles, Juan S. Barajas-Gamboa, Joana Ferrer-Fàbrega, Matthew Kroh. Bariatric surgery in liver transplant: Current trends and future perspectivesCirugía Española (English Edition) 2022; 100(2): 59 doi: 10.1016/j.cireng.2021.04.021
156
Danyan Ma, Jinyang Zeng, Bingkun Huang, Fangfang Yan, Jiawen Ye, Yun Chen, Xiying Zeng, Xin Zheng, Fangsen Xiao, Mingzhu Lin, Changqin Liu, Zhibin Li. Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adultsBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02011-0
157
Abdulrahman Ismaiel, Ayman Jaaouani, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-AnalysisBiomedicines 2021; 9(12): 1890 doi: 10.3390/biomedicines9121890
158
Xiaoyan Zhang, Jingxin Li, Tiancai Liu, Min Zhao, Baozhu Liang, Hong Chen, Zhen Zhang, Ihtisham Bukhari. Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric SurgeryDisease Markers 2022; 2022: 1 doi: 10.1155/2022/4369329
159
Ryoko Tajima, Fumiaki Imamura, Takeshi Kimura, Satomi Kobayashi, Katsunori Masuda, Kaoruko Iida. Association of alcohol consumption with prevalence of fatty liver after adjustment for dietary patterns: Cross-sectional analysis of Japanese middle-aged adultsClinical Nutrition 2020; 39(5): 1580 doi: 10.1016/j.clnu.2019.07.001
160
Anton Gillessen, Francesco Angelico, Jun Chen, Lungen Lu, Maria Isabel Lucena, Qingchun Fu, Qing Xie, Raul J. Andrade, Wen Xie, Xiaoyuan Xu, Yanyan Yu, Yi-min Mao, Yuemin Nan. Silymarin for Treating Toxic Liver Disease: International Consensus RecommendationsGastro Hep Advances 2022; 1(5): 882 doi: 10.1016/j.gastha.2022.05.006
161
Jai Kumar, Sana Mohsin, Misha Hasan, Abdur Raheem Bilal, Kumail Mustafa Ali, Ahmed Umer, Dua Zehra Mohammad Hadi, Sanjna Nandlal, Sarwan Kumar. Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology 2024; 48(1): 102261 doi: 10.1016/j.clinre.2023.102261
162
Jane Ha, Sun Young Yim, Raffi Karagozian. Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology 2023; 21(10): 2496 doi: 10.1016/j.cgh.2022.11.019
163
Kelly Casler, Amanda Chaney. CirrhosisNursing 2021; 51(2): 24 doi: 10.1097/01.NURSE.0000731828.24893.bb
164
Valentin Metzner, Gloria Herzog, Tobias Heckel, Thorsten Bischler, Julia Hasinger, Christoph Otto, Martin Fassnacht, Andreas Geier, Florian Seyfried, Ulrich Dischinger. Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic ImprovementsJournal of Clinical Medicine 2022; 11(3): 753 doi: 10.3390/jcm11030753
165
Sze Zee Lim, Kee Huat Chuah, Ruveena Bhavani Rajaram, Khoo Stanley, Shahreedhan Shahrani, Wah Kheong Chan, Shiaw Hooi Ho, Ida Normiha Hilmi, Khean Lee Goh, Sanjiv Mahadeva. Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single‐center observational studyJournal of Gastroenterology and Hepatology 2022; 37(9): 1732 doi: 10.1111/jgh.15905
166
Stephen D. H. Malnick, Pavel Alin, Marina Somin, Manuela G. Neuman. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but DifferentInternational Journal of Molecular Sciences 2022; 23(24): 16226 doi: 10.3390/ijms232416226
167
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and TreatmentFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
168
Tiantian Song, Shuchun Chen, Hang Zhao, Fei Wang, Huan Song, Dongliang Tian, Qiwen Yang, Licui Qi. Meta‐analysis of the effect of sodium–glucose cotransporter 2 inhibitors on hepatic fibrosis in patients with type 2 diabetes mellitus complicated with non‐alcoholic fatty liver diseaseHepatology Research 2021; 51(6): 641 doi: 10.1111/hepr.13645
169
Keyvan Hejazi, Daniel Hackett. Effect of Exercise on Liver Function and Insulin Resistance Markers in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsJournal of Clinical Medicine 2023; 12(8): 3011 doi: 10.3390/jcm12083011
170
Hassan M. Heshmati. Advances in Hepatology2021;  doi: 10.5772/intechopen.97568
171
Hannah Collins, Grant Beban, John Windsor, Rishi Ram, David Orr, Nicholas Evennett, Benjamin Loveday. Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand SettingObesity Surgery 2020; 30(1): 313 doi: 10.1007/s11695-019-04161-3
172
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans‐Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon‐Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guidelineUnited European Gastroenterology Journal 2022; 10(7): 663 doi: 10.1002/ueg2.12280
173
M. V. Kruchinina, M. V. Parulikova, A. V. Belkovets, K. Yu. Nikolaev, A. K. Ovsyannikova. Features of the fatty acid profile of erythrocyte membranes in patients with fatty liver disease of alcoholic genesisMeditsinskiy sovet = Medical Council 2023; (18): 84 doi: 10.21518/ms2023-391
174
Dou-Dou Li, Jia-Min Ma, Ming-Jing Li, Lu-Lu Gao, Yan-Na Fan, Yan-Nan Zhang, Xiu-Juan Tao, Jian-Jun Yang. Supplementation of Lycium barbarum Polysaccharide Combined with Aerobic Exercise Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis via AMPK/PPARα/PGC-1α PathwayNutrients 2022; 14(15): 3247 doi: 10.3390/nu14153247
175
D. V. Garbuzenko. Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver FibrosisRussian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 31(5): 16 doi: 10.22416/1382-4376-2021-31-5-16-24
176
Azadeh Hojreh, Julia Lischka, Dietmar Tamandl, Dariga Ramazanova, Amra Mulabdic, Susanne Greber-Platzer, Ahmed Ba-Ssalamah. Relative Enhancement in Gadoxetate Disodium-Enhanced Liver MRI as an Imaging Biomarker in the Diagnosis of Non-Alcoholic Fatty Liver Disease in Pediatric ObesityNutrients 2023; 15(3): 558 doi: 10.3390/nu15030558
177
Benedikt Kaufmann, Nick Seyfried, Daniel Hartmann, Phillipp Hartmann. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver diseaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 325(1): G42 doi: 10.1152/ajpgi.00017.2023
178
Danqing Hu, Peng Wang, Xiaojing Wang, Xue Hu, Da Huang, Weiming Yan, Dong Xi, Meifang Han, Qin Ning, Hongwu Wang. Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLDJournal of the Formosan Medical Association 2023;  doi: 10.1016/j.jfma.2023.12.001
179
Daniel Faurholt-Jepsen, Henrik Friis, David L. Mwaniki, Michael K. Boit, Lydia U. Kaduka, Inge Tetens, Dirk L. Christensen, Giacomo Pucci. Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adultsPLOS ONE 2021; 16(2): e0247600 doi: 10.1371/journal.pone.0247600
180
Saber Ghiassi, Maher El Chaar, Essa M. Aleassa, Fady Moustarah, Sofiane El Djouzi, T. Javier Birriel, Ann M. Rogers. ASMBS position statement on the relationship between obesity and cancer, and the role of bariatric surgery: risk, timing of treatment, effects on disease biology, and qualification for surgerySurgery for Obesity and Related Diseases 2020; 16(6): 713 doi: 10.1016/j.soard.2020.03.019
181
Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-AnalysisJournal of Clinical Medicine 2021; 10(14): 3029 doi: 10.3390/jcm10143029
182
Hao Han, Yan Guo, Xiaoyu Li, Dongxing Shi, Tingli Xue, Linqi Wang, Yanyan Li, Mingming Zheng. Plant Sterol Ester of α-Linolenic Acid Attenuates Nonalcoholic Fatty Liver Disease by Rescuing the Adaption to Endoplasmic Reticulum Stress and Enhancing Mitochondrial BiogenesisOxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/8294141
183
Mithun Sharma, Madhumita Premkumar, Anand V Kulkarni, Pramod Kumar, D Nageshwar Reddy, Nagaraja Padaki Rao. Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy GrailJournal of Clinical and Translational Hepatology 2020; 0(000): 1 doi: 10.14218/JCTH.2020.00055
184
Anouk Charlot, Joffrey Zoll. Beneficial Effects of the Ketogenic Diet in Metabolic Syndrome: A Systematic ReviewDiabetology 2022; 3(2): 292 doi: 10.3390/diabetology3020020
185
Eduardo Lemos De Souza Bastos, Almino Ramos Cardoso. The Perfect Sleeve Gastrectomy2020; : 19 doi: 10.1007/978-3-030-28936-2_3
186
Wangya Jia, Keke Wang, Shaobo Zhang, Wenxu Lu, Ao Du, Jian Li, Lili Ji, Hong Xu. Integrating network pharmacology and in vivo experimental validation to reveal the alleviation of mailuoning oral liquid on non-alcoholic fatty liver diseasePhytomedicine 2022; 104: 154326 doi: 10.1016/j.phymed.2022.154326
187
MoezAlIslam Faris, Haitham Jahrami, Dana Abdelrahim, Nicola Bragazzi, Ahmed BaHammam. The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regressionDiabetes Research and Clinical Practice 2021; 178: 108951 doi: 10.1016/j.diabres.2021.108951
188
Kay Craven, Donna Clement, Caroline T. Brewster, Jamie Messenger, Kathryn M. Kolasa. Non-Alcoholic Fatty Liver Disease (NAFLD) and NutritionNutrition Today 2021; 56(6): 296 doi: 10.1097/NT.0000000000000514
189
Elena-Daniela Grigorescu, Mariana Floria, Cristina Mihaela Lăcătușu, Bogdan Mircea-Mihai, Ioana Creţu, Alina Delia Popa, Alina Onofriescu, Irina M. Jaba, Victoriţa Șorodoc, Alexandr Ceasovschih, Laurenţiu Șorodoc. The Relationship between Hepatic Steatosis, inflammation and insulin Resistance in type 2 Diabetes with Metabolic ImbalanceInternal Medicine 2019; 16(4): 13 doi: 10.2478/inmed-2019-0073
190
Qun Liu, Shousheng Liu, Lizhen Chen, Zhenzhen Zhao, Shuixian Du, Quanjiang Dong, Yongning Xin, Shiying Xuan. Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)Experimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7781
191
Lorena Fecury Tavares, Mariana Rosa Bernardo, Kalil Orleans Silveira Pinho, Ana Paula Santos Oliveira Brito, Rodrigo Bona Maneschy, Hamilton Cezar Rocha de Garcia. Doença Hepática Gordurosa Não Alcoólica - Diagnóstico e tratamentoPará Research Medical Journal 2022; 3(2): 1 doi: 10.4322/prmj.2019.011
192
Abdulrahman Ismaiel, Blal El Hosiny, Mohamed Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Cristina Sorina Catana, Dan L. Dumitrascu. Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology 2023; 47(7): 102160 doi: 10.1016/j.clinre.2023.102160
193
Gabriela Xavier Ortiz, Gabriele Lenhart, Matheus William Becker, Karin Hepp Schwambach, Cristiane Valle Tovo, Carine Raquel Blatt. Drug-induced liver injury and COVID-19: A review for clinical practiceWorld Journal of Hepatology 2021; 13(9): 1143-1153 doi: 10.4254/wjh.v13.i9.1143
194
Meng-Hsun Yu, Tung-Wei Hung, Chi-Chih Wang, Sheng-Wen Wu, Tzu-Wei Yang, Ching-Yu Yang, Tsui-Hwa Tseng, Chau-Jong Wang. Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In VitroInternational Journal of Molecular Sciences 2021; 22(23): 13163 doi: 10.3390/ijms222313163
195
Philip N. Newsome, Kristine Buchholtz, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun J. Sanyal, Anne-Sophie Sejling, Stephen A. Harrison. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic SteatohepatitisNew England Journal of Medicine 2021; 384(12): 1113 doi: 10.1056/NEJMoa2028395
196
Sevket Balta. Atherosclerosis and Non-Alcoholic Fatty Liver DiseaseAngiology 2022; 73(8): 701 doi: 10.1177/00033197221091317
197
Nuria Perez-Diaz-del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, Itziar Abete, M. Angeles Zulet. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) StudyEuropean Journal of Nutrition 2021; 60(6): 3043 doi: 10.1007/s00394-020-02476-x
198
Satu Korpimäki, Suvi P Rovio, Markus Juonala, Nina Hutri-Kähönen, Terho Lehtimäki, Tomi P Laitinen, Päivi Tossavainen, Eero Jokinen, Britt-Marie Loo, Satu Männistö, Tuija Tammelin, Atte Haarala, Heikki Aatola, Gaber Komar, Jorma Viikari, Olli Raitakari, Mika Kähönen, Katja Pahkala. Nonalcoholic Fatty Liver Disease Incidence and Remission and Their Predictors During 7 Years of Follow-up Among FinnsThe Journal of Clinical Endocrinology & Metabolism 2023; 109(1): e291 doi: 10.1210/clinem/dgad418
199
Marc-Olivier Deguise, Chantal Pileggi, Yves De Repentigny, Ariane Beauvais, Alexandra Tierney, Lucia Chehade, Jean Michaud, Maica Llavero-Hurtado, Douglas Lamont, Abdelmadjid Atrih, Thomas M. Wishart, Thomas H. Gillingwater, Bernard L. Schneider, Mary-Ellen Harper, Simon H. Parson, Rashmi Kothary. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver DiseaseCellular and Molecular Gastroenterology and Hepatology 2021; 12(1): 354 doi: 10.1016/j.jcmgh.2021.01.019
200
Khalid Alswat, Faisal M Sanai, Waleed Al-hamoudi, Mona Ismail, Yaser Dahlan, Hamdan Saleh AlGhamdi, Ibrahim Altraif, Abduljaleel Alalwan, Mohamed MA Babatin, Saleh A Alqahtani. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) RegistryDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1167 doi: 10.2147/DMSO.S300051
201
Yongin Cho, Yong-ho Lee. State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic SteatohepatitisEndocrinology and Metabolism 2022; 37(1): 38 doi: 10.3803/EnM.2022.102
202
Elizabeth R. M. Zunica, Elizabeth C. Heintz, Christopher L. Axelrod, John P. Kirwan. Obesity Management in the Primary Prevention of Hepatocellular CarcinomaCancers 2022; 14(16): 4051 doi: 10.3390/cancers14164051
203
Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, Giampiero Francica. A critical appraisal of the use of ultrasound in hepatic steatosisExpert Review of Gastroenterology & Hepatology 2019; 13(7): 667 doi: 10.1080/17474124.2019.1621164
204
Chayanis Kositamongkol, Thammanard Charernboon, Thanet Chaisathaphol, Chaiwat Washirasaksiri, Chonticha Auesomwang, Tullaya Sitasuwan, Phunchai Charatcharoenwitthaya, Pochamana Phisalprapa. Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndromeMedicine 2021; 100(44): e27640 doi: 10.1097/MD.0000000000027640
205
Li‐Wei Chen, Mi‐Sio Huang, Yu‐Chiau Shyu, Rong‐Nan Chien. Gamma‐glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community‐based cross‐sectional studyThe Kaohsiung Journal of Medical Sciences 2021; 37(9): 819 doi: 10.1002/kjm2.12395
206
Zhen-Shu Liu, Pei-Lin Li, Yu-We Ku, Po-Wen Chen. Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in MiceMicroorganisms 2022; 10(11): 2215 doi: 10.3390/microorganisms10112215
207
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, Ali Beheshti Namdar, Hassan Vossoughinia, Mohammadreza Farzanehfar. A review of non‐alcoholic fatty liver disease in non‐obese and lean individualsJournal of Gastroenterology and Hepatology 2021; 36(6): 1497 doi: 10.1111/jgh.15353
208
Shirley Yuk-Wah Liu, Vincent Wai-Sun Wong, Simon Kin-Hung Wong, Grace Lai-Hung Wong, Carol Man-sze Lai, Candice Chuen-Hing Lam, Sally She-Ting Shu, Henry Lik-Yuen Chan, Enders Kwok-Wai Ng. A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgeryScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83782-0
209
Allison M. Carroll, Yaron Rotman. Nutrition Literacy Is Not Sufficient to Induce Needed Dietary Changes in Nonalcoholic Fatty Liver DiseaseAmerican Journal of Gastroenterology 2023; 118(8): 1381 doi: 10.14309/ajg.0000000000002182
210
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena Shirokova, Kirill M Starostin. Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in RussiaBMJ Open Gastroenterology 2019; 6(1): e000307 doi: 10.1136/bmjgast-2019-000307
211
Hasen A. Al-ghamdi, Fayza F. Al Fayez, Abdulhadi I. Bima, Taghreed M. Khawaji, Ayman Z. Elsamanoudy. Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D SupplementationJournal of Clinical and Experimental Hepatology 2021; 11(2): 219 doi: 10.1016/j.jceh.2020.07.003
212
Javier Vázquez-Bourgon, Víctor Ortiz-García de la Foz, Irene Suarez-Pereira, Paula Iruzubieta, María Teresa Arias-Loste, Esther Setién-Suero, Rosa Ayesa-Arriola, Marcos Gómez-Revuelta, Javier Crespo, Benedicto Crespo Facorro. Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patientsProgress in Neuro-Psychopharmacology and Biological Psychiatry 2019; 95: 109677 doi: 10.1016/j.pnpbp.2019.109677
213
Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual DysfunctionFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
214
Xiongfeng Pan, Shi Wu Wen, Atipatsa C. Kaminga, Aizhong Liu. Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65051-8
215
Lvying Wu, Lei Xing, Yake Zou, Zichen Wang, Yuanyuan Li, Lei Zhang, Su Guan. UPLC-QTOF-MS Based Comparison of Rotundic Acid Metabolic Profiles in Normal and NAFLD RatsSSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4005127
216
Priyanka Bhandari, Amit Sapra, Mohitkumar S Ajmeri, Christine E Albers, Devanshika Sapra. Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?Cureus 2022;  doi: 10.7759/cureus.23806
217
Mohammad Sadiq Jeeyavudeen, Shahanas K A Khan, Sherouk Fouda, Joseph M Pappachan. Management of metabolic-associated fatty liver disease: The diabetology perspectiveWorld Journal of Gastroenterology 2023; 29(1): 126-143 doi: 10.3748/wjg.v29.i1.126
218
Amir Mari, Tawfik Khoury, Helal Said Ahmad, Fadi Abu Baker, Anas Kadah, Wisam Sbeit, Rinaldo Pellicano, Mahmud Mahamid. The association between non-alcoholic fatty liver disease and valvular heart diseaseMinerva Cardioangiologica 2020; 68(1) doi: 10.23736/S0026-4725.19.05087-4
219
Mustafa Al-Karaghouli, Sonia Fuentes, Tracy Davyduke, Mang Ma, Juan G Abraldes. Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLDBMJ Open Gastroenterology 2022; 9(1): e000798 doi: 10.1136/bmjgast-2021-000798
220
Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina. Nonalcoholic fatty liver disease and cardiovascular disease phenotypesSAGE Open Medicine 2020; 8: 205031212093380 doi: 10.1177/2050312120933804
221
Anna Laitakari, Joona Tapio, Kari A. Mäkelä, Karl-Heinz Herzig, Franziska Dengler, Helena Gylling, Gail Walkinshaw, Johanna Myllyharju, Elitsa Y. Dimova, Raisa Serpi, Peppi Koivunen. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLDJournal of Molecular Medicine 2020; 98(5): 719 doi: 10.1007/s00109-020-01903-0
222
Philip Berry, Sreelakshmi Kotha. The Challenging Ethical Landscape of Non-alcoholic Fatty Liver DiseaseEMJ Hepatology 2022;  doi: 10.33590/emjhepatol/21-00217
223
Macarena Ortiz, Sandra A. Soto-Alarcón, Paula Orellana, Alejandra Espinosa, Cristian Campos, Sandra López-Arana, Miguel A. Rincón, Paola Illesca, Rodrigo Valenzuela, Luis A. Videla. Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administrationDigestive and Liver Disease 2020; 52(8): 895 doi: 10.1016/j.dld.2020.04.019
224
Mohammad H. Jamal, Rawan El-Abd. Laparoscopic Sleeve Gastrectomy2021; : 115 doi: 10.1007/978-3-030-57373-7_15
225
Nuria Perez-Diaz-del-Campo, Jose I. Riezu-Boj, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Fermín I. Milagro, Josep A. Tur, Itziar Abete, M. Angeles Zulet, J. Alfredo Martinez. Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity StudyDiagnostics 2021; 11(6): 1083 doi: 10.3390/diagnostics11061083
226
Shengnan Tang, Jin Wu, Shanshan Xu, Qi Li, Jian He. Clinical-radiomic analysis for non-invasive prediction of liver steatosis on non-contrast CT: A pilot studyFrontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1071085
227
Ana J. F. C. Aguiar, Jaluza L. C. de Queiroz, Pedro P. A. Santos, Christina S. Camillo, Alexandre C. Serquiz, Izael S. Costa, Gerciane S. Oliveira, Ana F. T. Gomes, Lídia L. R. Matias, Rafael O. A. Costa, Thaís S. Passos, Ana H. A. Morais. Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical StudyInternational Journal of Molecular Sciences 2021; 22(18): 9968 doi: 10.3390/ijms22189968
228
Caroline Chong Nguyen, Denis Duboc, Dominique Rainteau, Harry Sokol, Lydie Humbert, Philippe Seksik, Adèle Bellino, Hendy Abdoul, Naïm Bouazza, Jean-Marc Treluyer, Malika Saadi, Karim Wahbi, Heithem Soliman, Benoit Coffin, André Bado, Maude Le Gall, Olivier Varenne, Henri Duboc. Circulating bile acids concentration is predictive of coronary artery disease in humanScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02144-y
229
Luke V. Selby, Aslam Ejaz, Stacy A. Brethauer, Timothy M. Pawlik. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgeryExpert Opinion on Investigational Drugs 2020; 29(2): 107 doi: 10.1080/13543784.2020.1721457
230
Jennifer Linge, Mattias Ekstedt, Olof Dahlqvist Leinhard. Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLDJHEP Reports 2021; 3(1): 100197 doi: 10.1016/j.jhepr.2020.100197
231
Chutian Wu, Yun Zhou, Min Wang, Guolin Dai, Xiongxiu Liu, Leizhen Lai, Shaohui Tang. Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver DiseaseFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.772487
232
Hyun-Ji Kim, Eun Bok Baek, Ji-Hee Hwang, Minyoung Lim, Won Hoon Jung, Myung Ae Bae, Hwa-Young Son, Jae-Woo Cho. Application of convolutional neural network for analyzing hepatic fibrosis in miceJournal of Toxicologic Pathology 2023; 36(1): 21 doi: 10.1293/tox.2022-0066
233
Md. Jahangir Alam, Sanjay K. Banerjee. Biochemistry of Cardiovascular Dysfunction in Obesity2020; : 15 doi: 10.1007/978-3-030-47336-5_2
234
Fátima Higuera-de-la-Tijera, Jacqueline Córdova-Gallardo, Elizabeth Buganza-Torio, Beatriz Barranco-Fragoso, Aldo Torre, Sara Parraguirre-Martínez, Martin Edgardo Rojano-Rodríguez, Gabriel Quintero-Bustos, Graciela Castro-Narro, Carlos Moctezuma-Velazquez. Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive ValueDigestive Diseases and Sciences 2021; 66(12): 4501 doi: 10.1007/s10620-020-06821-2
235
Silvia Ferri, Bernardo Stefanini, Lorenzo Mulazzani, Margherita Alvisi, Francesco Tovoli, Simona Leoni, Luca Muratori, Tommaso Lotti, Alessandro Granito, Luigi Bolondi, Fabio Piscaglia. Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver DiseaseNutrients 2022; 14(12): 2493 doi: 10.3390/nu14122493
236
Mohammed Eslam, Shiv K. Sarin, Vincent Wai-Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming-Hua Zheng, Gamal Shiha, Yusuf Yilmaz, Rino Gani, Shahinul Alam, Yock Young Dan, Jia-Horng Kao, Saeed Hamid, Ian Homer Cua, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata, Jacob George. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseaseHepatology International 2020; 14(6): 889 doi: 10.1007/s12072-020-10094-2
237
Iresha Sandamali Koralegedara, Janith Niwanthaka Warnasekara, Ashani Rathnayake, Korale Gedara Dayaratne, Suneth Buddhika Agampodi. Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancyBMJ Open Gastroenterology 2022; 9(1): e000913 doi: 10.1136/bmjgast-2022-000913
238
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and ManagementEndocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
239
Atilla BEKTAS, Meltem ULUSOY, Kemal DAĞALP. Ursodeoksikolik Asit, Diyabetik Olmayan, Alkol Dışı Karaciğer Yağlanması Tedavisinde Yer Almalı Mı?Konuralp Tıp Dergisi 2020; 12(1): 44 doi: 10.18521/ktd.527978
240
Wah‐Kheong Chan, Soek‐Siam Tan, Siew‐Pheng Chan, Yeong‐Yeh Lee, Hoi‐Poh Tee, Sanjiv Mahadeva, Khean‐Lee Goh, Anis Safura Ramli, Feisul Mustapha, Nik Ritza Kosai, Raja Affendi Raja Ali. Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver diseaseJournal of Gastroenterology and Hepatology 2022; 37(5): 795 doi: 10.1111/jgh.15787
241
Joscha Vonderlin, Triantafyllos Chavakis, Michael Sieweke, Frank Tacke. The Multifaceted Roles of Macrophages in NAFLD PathogenesisCellular and Molecular Gastroenterology and Hepatology 2023; 15(6): 1311 doi: 10.1016/j.jcmgh.2023.03.002
242
A.J. Scheen. Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complicationsDiabetes & Metabolism 2019; 45(3): 213 doi: 10.1016/j.diabet.2019.01.008
243
Luisa Barana, Georgia Colleluori, Maria Teresa Sulpizi, Kathleen Ortenzi, Luca Farano, Carmine Giuseppe Fanelli, Riccardo Calafiore, Laura Dalla Ragione, Simone Pampanelli. Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eatingJournal of Diabetes & Metabolic Disorders 2022; 21(2): 1883 doi: 10.1007/s40200-022-01085-1
244
Yunpeng Gu, Wei Zhang, Yanli Hu, Yutong Chen, Junping Shi. Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studiesJournal of Affective Disorders 2022; 301: 8 doi: 10.1016/j.jad.2021.12.128
245
Gerardo Sarno, Luigi Schiavo, Pietro Calabrese, Ludwig Álvarez Córdova, Evelyn Frias-Toral, Gabriela Cucalón, Eloisa Garcia-Velasquez, Vanessa Fuchs-Tarlovsky, Vincenzo Pilone. The Impact of Bariatric-Surgery-Induced Weight Loss on Patients Undergoing Liver Transplant: A Focus on Metabolism, Pathophysiological Changes, and Outcome in Obese Patients Suffering NAFLD-Related CirrhosisJournal of Clinical Medicine 2022; 11(18): 5293 doi: 10.3390/jcm11185293
246
Kenneth W. Chow, Pragyat Futela, Aryan Saharan, Sammy Saab. Comparison of Guidelines for the Screening, Diagnosis, and Noninvasive Assessment of Nonalcoholic Fatty Liver DiseaseJournal of Clinical and Experimental Hepatology 2023; 13(5): 783 doi: 10.1016/j.jceh.2023.01.016
247
Tae Jung Oh, Kyuho Kim, Jae Hoon Moon, Sung Hee Choi, Nam H Cho, Hak Chul Jang. Liver Fibrosis Indices for the Prediction of Mortality in Korean Subjects: A 16-Year Prospective Cohort StudyJournal of the Endocrine Society 2021; 5(10) doi: 10.1210/jendso/bvab123
248
Stephen A. Harrison, Vlad Ratziu, Jeremy Magnanensi, Yacine Hajji, Sylvie Deledicque, Zouher Majd, Christian Rosenquist, Dean W. Hum, Bart Staels, Quentin M. Anstee, Arun J. Sanyal. NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation studyJournal of Hepatology 2023; 79(3): 758 doi: 10.1016/j.jhep.2023.04.031
249
Giulia Besutti, Lisa Bonilauri, Elisa Manicardi, Francesco Venturelli, Efrem Bonelli, Filippo Monelli, Valeria Manicardi, Luca Valenti, Guido Ligabue, Susanna Schianchi, Marco Massari, Nicoletta Riva, Elisabetta Froio, Elena Tagliavini, Pierpaolo Pattacini, Paolo Giorgi Rossi. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective studyDiabetes Research and Clinical Practice 2021; 177: 108882 doi: 10.1016/j.diabres.2021.108882
250
М. В. Кручинина, М. В. Паруликова, Н. Е. Першина, Э. В. Кручинина. Жирные кислоты мембран эритроцитов как биомаркеры неалкогольной жировой болезни печени у мужчинAteroscleroz 2023; 18(4): 362 doi: 10.52727/2078-256X-2022-18-4-362-380
251
Maria Lilibeth Manzanilla Valdez, Maira Rubi Segura Campos. Renal and Hepatic Disease:Cnidoscolus aconitifoliusas Diet Therapy Proposal for Prevention and TreatmentJournal of the American College of Nutrition 2021; 40(7): 646 doi: 10.1080/07315724.2020.1810171
252
Ron S. Newfield, Carrie L. Graves, Robert O. Newbury, Jeffrey B. Schwimmer, James A. Proudfoot, Daphne S. Say, Ariel E. Feldstein. Non‐alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjectsPediatric Diabetes 2018;  doi: 10.1111/pedi.12798
253
Stergios A. Polyzos, Eun Seok Kang, Chrysoula Boutari, Eun-Jung Rhee, Christos S. Mantzoros. Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitisMetabolism 2020; 111: 154203 doi: 10.1016/j.metabol.2020.154203
254
Jiajun Qiu, Maobin Kuang, Shiming He, Changhui Yu, Chao Wang, Xin Huang, Guotai Sheng, Yang Zou. Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general populationFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1302322
255
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeuticsMetabolism 2019; 92: 82 doi: 10.1016/j.metabol.2018.11.014
256
Taisiia Turankova, Oleg Blyuss, Alexey Brazhnikov, Andrey Svistunov, Kurinchi Selvan Gurusamy, Chavdar S Pavlov. Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver diseaseCochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013670
257
Qiu-Xuan Li, Han Gao, Yue-Xin Guo, Bo-Ya Wang, Rong-xuan Hua, Lei Gao, Hong-Wei Shang, Xin Lu, Jing-Dong Xu. GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASHFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.721198
258
Ralitsa Robeva, Dušan Mladenović, Milena Vesković, Dragan Hrnčić, Jelica Bjekić-Macut, Olivera Stanojlović, Sarantis Livadas, Bulent O. Yildiz, Djuro Macut. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopauseMaturitas 2021; 151: 22 doi: 10.1016/j.maturitas.2021.06.012
259
Xueqi Li, Xianjue Huang, Guangwen Cheng, Jing Liang, Luping Qiu, Jubo Zhang, Qiyuan Yao, Hong Ding. Optimizing the number of valid measurements for the attenuation coefficient to assess hepatic steatosis in MAFLD patients: A study of 139 patients who underwent liver biopsyUltraschall in der Medizin - European Journal of Ultrasound 2023;  doi: 10.1055/a-2178-5022
260
Gianni BELCARO, David M. COX, M. Rosaria CESARONE, Giuseppe GIZZI, Luciano PELLEGRINI, Claudia SCIPIONE, Valeria SCIPIONE, Mark DUGALL, Shu HU, Marcello CORSI, Beatrice FERAGALLI, Roberto COTELLESE. Effects of Robuvit® on the progression of non-alcoholic fatty liver diseaseMinerva Gastroenterology 2022; 68(4) doi: 10.23736/S2724-5985.22.03201-6
261
Liyuan Hao, Shenghao Li, Guo Chen, Xiaoyu Hu. Regulation of UCP2 in nonalcoholic fatty liver disease: From mechanisms to natural productChemical Biology & Drug Design 2024; 103(2) doi: 10.1111/cbdd.14461
262
Simona Cernea, Itamar Raz. NAFLDin type 2 diabetes mellitus: Still many challenging questionsDiabetes/Metabolism Research and Reviews 2021; 37(2) doi: 10.1002/dmrr.3386
263
Manal H. El-Sayed, Rasha A. Thabet, Mohamed T. Hamza, Muhammad S. Hussein, Maha M. El Saeed. Liver disease in children and adolescents with type 1 diabetes mellitus: A link between glycemic control and hepatopathyDiabetes Research and Clinical Practice 2020; 170: 108458 doi: 10.1016/j.diabres.2020.108458
264
Yi-Ning Dai, Cheng-Fu Xu, Hong-Ying Pan, Hai-Jun Huang, Mei-Juan Chen, You-Ming Li, Chao-Hui Yu. Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver diseaseWorld Journal of Clinical Cases 2022; 10(13): 4097-4109 doi: 10.12998/wjcc.v10.i13.4097
265
Begoña Lavin, Thomas R. Eykyn, Alkystis Phinikaridou, Aline Xavier, Shravan Kumar, Xabier Buqué, Patricia Aspichueta, Carlos Sing‐Long, Marco Arrese, René M. Botnar, Marcelo E. Andia. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitisNMR in Biomedicine 2023; 36(8) doi: 10.1002/nbm.4932
266
Maya Margalit, Hanny Yeshua, Neta Gotlieb, Shira Zelber-Sagi. NAFLD and NASH2020; : 11 doi: 10.1007/978-3-030-37173-9_2
267
Élise Vuille-Lessard, Naomi Lange, Carlotta Riebensahm, Jean-François Dufour, Annalisa Berzigotti. Dietary Interventions in Liver Diseases: Focus on MAFLD and CirrhosisCurrent Hepatology Reports 2021; 20(2): 61 doi: 10.1007/s11901-021-00563-z
268
Weijie Lin, Zhengrong Liu, Ling Li, Zhiling Zhou, Shiyu Ma, Fazhong He. Effects of Shugan Quzhi Capsule in treating different metabolic diseases based on network pharmacology and molecular docking2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2021; : 3832 doi: 10.1109/BIBM52615.2021.9669290
269
Yan Sun, Nie Zhang, Yun-Long Ding, Li-Jiang Yu, Jun Cai, De Ma, Wu Yang, Wang-Kun Lu, Jia-Li Niu. Effect of lipid metabolism disorder on liver function in patients with malignant tumors after chemotherapy: a case-control studyLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1063-y
270
Samy A. Azer, Rana Hasanato. Use of bile acids as potential markers of liver dysfunction in humansMedicine 2021; 100(41): e27464 doi: 10.1097/MD.0000000000027464
271
Carolina Castillo-Castro, Alexandro José Martagón-Rosado, Rocio Ortiz-Lopez, Luis Felipe Garrido-Treviño, Melissa Villegas-Albo, Francisco Javier Bosques-Padilla. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiomeWorld Journal of Hepatology 2021; 13(11): 1494-1511 doi: 10.4254/wjh.v13.i11.1494
272
Amedeo Lonardo. Metabolomic signature: one step forward in the process of obtaining NAFLD patients’ metabolic identity cardThe American Journal of Clinical Nutrition 2022; 115(3): 603 doi: 10.1093/ajcn/nqab399
273
Joanna Michałowska, Ewa Miller-Kasprzak, Paweł Bogdański. Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical PerspectiveNutrients 2021; 13(2): 351 doi: 10.3390/nu13020351
274
Livhuwani P. Nendouvhada, Nicole R. S. Sibuyi, Adewale O. Fadaka, Samantha Meyer, Abram M. Madiehe, Mervin Meyer, Kwazikwakhe B. Gabuza. Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver DiseaseInternational Journal of Molecular Sciences 2024; 25(11): 5571 doi: 10.3390/ijms25115571
275
Amani Al-Shargi, Amal A. El Kholy, Abdulmoneim Adel, Mohamed Hassany, Sara M. Shaheen. Allopurinol versus Febuxostat: A New Approach for the Management of Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver DiseaseBiomedicines 2023; 11(11): 3074 doi: 10.3390/biomedicines11113074
276
Sara De Nucci, Caterina Bonfiglio, Rosanna Donvito, Martina Di Chito, Nicole Cerabino, Roberta Rinaldi, Annamaria Sila, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Elsa Lanzilotta, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and ObesityNutrients 2023; 15(20): 4468 doi: 10.3390/nu15204468
277
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis DiagnosisFrontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.774079
278
Peizuo Zhao, Weidong Yang, Huiyu Xiao, Shuaishuai Zhang, Chuanzhou Gao, Hua Piao, Lihong Liu, Shuzhuang Li. Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat dietScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53644-6
279
Muhammad Usman, Nabiyah Bakhtawar. Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials Cureus 2020;  doi: 10.7759/cureus.9018
280
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical ApplicationsDiagnostics 2021; 11(5): 842 doi: 10.3390/diagnostics11050842
281
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guidelineClinical Nutrition 2022; 41(10): 2364 doi: 10.1016/j.clnu.2022.07.003
282
Hao Han, Tingli Xue, Jie Li, Yan Guo, Xiaoyu Li, Linqi Wang, Liyuan Pei, Mingming Zheng. Plant sterol ester of α-linolenic acid improved non-alcoholic fatty liver disease by attenuating endoplasmic reticulum stress-triggered apoptosis via activation of the AMPKThe Journal of Nutritional Biochemistry 2022; 107: 109072 doi: 10.1016/j.jnutbio.2022.109072
283
Guoyan Jiang, Chunhong Sun, Xiaodong Wang, Jie Mei, Chen Li, Honghong Zhan, Yixuan Liao, Yongjun Zhu, Jingxin Mao. Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verificationBioengineered 2022; 13(3): 5216 doi: 10.1080/21655979.2022.2037374
284
Julita Tokarek, Emilian Budny, Maciej Saar, Kamila Stańczak, Ewa Wojtanowska, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and DiabetesBiomedicines 2023; 11(10): 2611 doi: 10.3390/biomedicines11102611
285
Julia Teck. Diabetes-Associated ComorbiditiesPrimary Care: Clinics in Office Practice 2022; 49(2): 275 doi: 10.1016/j.pop.2021.11.004
286
Hüseyin Vural, Ferah Armutcu, Omer Akyol, Ralf Weiskirchen. The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseasesClinica Chimica Acta 2021; 523: 374 doi: 10.1016/j.cca.2021.10.018
287
Yahya Pasdar, Farhad Oubari, Mahin Nikougoftar Zarif, Mehrnaz Abbasi, Azizollah Pourmahmoudi, Mahboobe Hosseinikia. Effects of Quercetin Supplementation on Hematological Parameters in Non-Alcoholic Fatty Liver Disease: a Randomized, Double-Blind, Placebo-Controlled Pilot StudyClinical Nutrition Research 2020; 9(1): 11 doi: 10.7762/cnr.2020.9.1.11
288
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventionsLife Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
289
Ji Won Kwak, Yong Jae Lee, Byoungjin Park, Dong Hyuk Jung. Combined effect of serum carcinoembryonic antigen and hepatic steatosis on new-onset ischemic heart disease among middle-aged and older Korean adults: a cohort studyFrontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1275450
290
Rita Basu, Mazen Noureddin, Jeanne M. Clark. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care ProvidersMayo Clinic Proceedings 2022; 97(9): 1700 doi: 10.1016/j.mayocp.2022.04.005
291
Rohitash Jamwal, Benjamin J. Barlock. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) EnzymesPharmaceuticals 2020; 13(9): 222 doi: 10.3390/ph13090222
292
Ming Li, Qian Wang, Yong Li, Shengtian Cao, Yingjun Zhang, Zhongqing Wang, Guozhu Liu, Jing Li, Baohua Gu. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challengesPharmacology & Therapeutics 2020; 212: 107539 doi: 10.1016/j.pharmthera.2020.107539
293
L.V. Zhuravlyova, O.V. Elhaj. THE ROLE OF RESISTIN IN THE PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASEInter Collegas 2021; 8(3): 157 doi: 10.35339/ic.8.3.157-162
294
Carlos Benítez, Juan Pablo Arab, Francisco Barrera, Jesus M. Banales, Marco Arrese. NAFLD and NASH2020; : 225 doi: 10.1007/978-3-030-37173-9_13
295
D. Yu. Venidiktova, A. V. Borsukov. Non-drug treatment of non-alcoholic fatty liver disease: evaluation of effectiveness with ultrasound steatometryMedical alphabet 2020; (10): 38 doi: 10.33667/2078-5631-2020-10-38-42
296
Mingshan Guo, Qianyu Pan, Xiaojin Shi, W. Du, S. Grasso. The Comparison and Contrast on NAFLD between the East and the West: Metabolic Mechanism, Dietary Habits, and PoliciesE3S Web of Conferences 2021; 308: 02021 doi: 10.1051/e3sconf/202130802021
297
Ysabel C. Ilagan-Ying, Bubu A. Banini, Albert Do, Robert Lam, Joseph K. Lim. Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical PracticeCurrent Gastroenterology Reports 2023; 25(10): 213 doi: 10.1007/s11894-023-00883-8
298
Eira Cerda-Reyes, Alicia Sarahi Ojeda-Yuren, Julián Torres-Vazquez, María del Rosario Herrero Maceda, Martín Uriel Vázquez-Medina, Perla Denice Flores-Rangel, Yailin Fabiola Velásquez Palacios, Saraid Cerda-Reyes, Graciela Elia Castro-Narro. Advances in Hepatology2021;  doi: 10.5772/intechopen.96281
299
Danielle Chi, Meghan Burk. What You Should Know About Fatty Liver DiseaseADCES in Practice 2020; 8(4): 34 doi: 10.1177/2633559X20928918
300
Bernardo Stefanini, Matteo Tonnini, Ilaria Serio, Matteo Renzulli, Francesco Tovoli. Surveillance for hepatocellular carcinoma: current status and future perspectives for improvementExpert Review of Anticancer Therapy 2022; 22(4): 371 doi: 10.1080/14737140.2022.2052276
301
Tony (Dazhong) Huang, Jason Behary, Amany Zekry. Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and managementInternal Medicine Journal 2020; 50(9): 1038 doi: 10.1111/imj.14709
302
Valentin Blank, David Petroff, Sebastian Beer, Albrecht Böhlig, Maria Heni, Thomas Berg, Yvonne Bausback, Arne Dietrich, Anke Tönjes, Marcus Hollenbach, Matthias Blüher, Volker Keim, Johannes Wiegand, Thomas Karlas. Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discriminationScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75227-x
303
Amirreza Naseri, Sarvin Sanaie, Sina Hamzehzadeh, Sepideh Seyedi-Sahebari, Mohammad-Salar Hosseini, Elnaz Gholipour-khalili, Ehsan Rezazadeh-Gavgani, Reza Majidazar, Parya Seraji, Sara Daneshvar, Erfan Rezazadeh-Gavgani. Metformin: new applications for an old drugJournal of Basic and Clinical Physiology and Pharmacology 2023; 34(2): 151 doi: 10.1515/jbcpp-2022-0252
304
J.M. Carrascosa, E. Vilarrasa, I. Belinchón, P. Herranz, J. Crespo, F. Guimerá, A. Olveira. Abordaje común del paciente con psoriasis y riesgo de esteatosis hepática metabólica: recomendaciones de un grupo de expertos multidisciplinarActas Dermo-Sifiliográficas 2023; 114(5): 392 doi: 10.1016/j.ad.2023.01.004
305
Yanqin Wang, Jiaqi Bo, Zhonghua Zhao, Yuhang Han, Qianqian Zhang, Lixin Liu. Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosisLife Sciences 2023; 332: 122086 doi: 10.1016/j.lfs.2023.122086
306
Rasika Pradeep Herath, Shirom R. Siriwardana, Chanil D. Ekanayake, Vikum Abeysekara, Sajith U. A. Kodithuwakku, Himali P. Herath, Jonathan M. Peterson. Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical studyPLOS ONE 2019; 14(4): e0215326 doi: 10.1371/journal.pone.0215326
307
Sarah Theurer, Julia Kälsch, Suzan Schwertheim, Simone Kathemann, Hideo A. Baba. Histopathologische Diagnostik und Differenzialdiagnostik der nichtalkoholischen FettlebererkrankungDer Pathologe 2020; 41(5): 434 doi: 10.1007/s00292-020-00800-0
308
Jia-Zhen Zhang, Jing-Jing Cai, Yao Yu, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease: An Update on the DiagnosisGene Expression 2019; 19(3): 187 doi: 10.3727/105221619X15553433838609
309
Ghulam Fatima, Kaneez Zainab Rabail, Mona Humaira, Afsana Khaskheli, Benazir Bughio, Kashaf Nida. Frequency of Liver Fibrosis by Non Invasive Marker in Patients with Non-Alcohol Fatty Liver DiseasesPakistan Journal of Health Sciences 2023; : 99 doi: 10.54393/pjhs.v4i02.572
310
Jia Han, Xin Guo, Tomoyuki Koyama, Daichi Kawai, Jing Zhang, Reimon Yamaguchi, Xiaolei Zhou, Yoshiharu Motoo, Takumi Satoh, Sohsuke Yamada. Zonarol Protected Liver from Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in a Mouse ModelNutrients 2021; 13(10): 3455 doi: 10.3390/nu13103455
311
Chuanrui Ma, Xinyu Wang, Jing Zhang, Yun Zhao, Yunqing Hua, Chao Zhang, Guobin Zheng, Guangyan Yang, Jianli Guan, Huahuan Li, Meng Li, Lin Kang, Jiaqing Xiang, Guanwei Fan, Shu Yang. Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental ValidationFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.893336
312
Vera Francisco, Maria Jesus Sanz, José T. Real, Patrice Marques, Maurizio Capuozzo, Djedjiga Ait Eldjoudi, Oreste Gualillo. Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?Biology 2022; 11(8): 1237 doi: 10.3390/biology11081237
313
Zahra Heidari, Zahra Sharafi. Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional StudyIranian South Medical Journal 2022; 25(1): 30 doi: 10.52547/ismj.25.1.30
314
Vicki Shah, Thomas Colletti, Nancy Reau. Could the answer to NAFLD be hidden in diabetic therapy? The impact of T2DM treatment on NAFLDClinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000100
315
Kaoru Shibayama, Chie Furushima, Minako Saka, Takako Sakamoto, Hirokazu Takahashi. Barriers to lifestyle modification in patients with non-alcoholic fatty liver disease: a scoping reviewJournal of Rural Medicine 2024; 19(1): 1 doi: 10.2185/jrm.2023-026
316
Yan Li, Chunyi Wang, Yu Jin, Haibo Chen, Meiqun Cao, Weimin Li, Huanmin Luo, Zhengzhi Wu. Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed ratsBiomedicine & Pharmacotherapy 2020; 126: 109734 doi: 10.1016/j.biopha.2019.109734
317
José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Ribeiro Leite Altikes, Claudia P. Oliveira. Non-pharmacological management options for MAFLD: a practical guideTherapeutic Advances in Endocrinology and Metabolism 2023; 14: 204201882311603 doi: 10.1177/20420188231160394
318
Vittoria Manilla, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani. Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to CancerNutrients 2023; 15(11): 2521 doi: 10.3390/nu15112521
319
Dana Gharib, Mohammed Mohammed, Taha Al-Karboly, Heero Faraj, Kawa Mahmood, Nasr Qazi, Karok Salih, Omar Azeez. VALUE OF TRANS-ABDOMINAL ULTRASOUND-GUIDED PERCUTANEOUS LIVER BIOPSY IN PATIENTS WITH FOCAL OR DIFFUSE LIVER LESIONS IN KURDISTAN CENTRE FOR GASTROENTEROLOGY AND HEPATOLOGY IN SULAIMANI CITYJOURNAL OF SULAIMANI MEDICAL COLLEGE 2020; 10(2): 199 doi: 10.17656/jsmc.10258
320
Qing Gu, Li Cen, Jiawei Lai, Zhongchen Zhang, Jiaqi Pan, Feng Zhao, Chaohui Yu, Youming Li, Chunxiao Chen, Weixing Chen, Zhe Shen. A meta‐analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver diseaseEuropean Journal of Clinical Investigation 2021; 51(2) doi: 10.1111/eci.13446
321
Jun Noichi, Tomoko Ishiakawa, Ikuyo Ichi, Yoko Fujiwara. Effect of tocotrienol on the primary progression of nonalcoholic steatohepatitis in a mouse modelJournal of Clinical Biochemistry and Nutrition 2022; 70(2): 140 doi: 10.3164/jcbn.21-69
322
Pierpaolo Pellicori, Muthiah Vaduganathan, João Pedro Ferreira, Faiez Zannad, Arun J. Sanyal. Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial designDiabetes & Metabolism 2022; 48(2): 101281 doi: 10.1016/j.diabet.2021.101281
323
Dimitrios A. Koutoukidis, Constantinos Koshiaris, John A. Henry, Michaela Noreik, Elizabeth Morris, Indrani Manoharan, Kate Tudor, Emma Bodenham, Anna Dunnigan, Susan A. Jebb, Paul Aveyard. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysisMetabolism 2021; 115: 154455 doi: 10.1016/j.metabol.2020.154455
324
Xueqi Li, Wenjun Ma, Ting Yang, Chong Wang, Wei Zhang, Hui Li, Ting Zhao, Xiaofei Guo. Higher intakes of lysine, threonine and valine are inversely associated with non-alcoholic fatty liver disease risk: a community-based case-control study in the Chinese elderlyFood Science and Human Wellness 2024; 13(1): 191 doi: 10.26599/FSHW.2022.9250016
325
Haiyan Liu, Jie Xu, Hui Li, Lina Zhang, Pingzhen Xu. Network pharmacology‐based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver diseaseThe Anatomical Record 2021; 304(11): 2605 doi: 10.1002/ar.24770
326
Valeria Calcaterra, Vittoria Magenes, Matteo Vandoni, Clarissa Berardo, Luca Marin, Alice Bianchi, Erika Cordaro, Giustino Silvestro, Dario Silvestri, Vittoria Carnevale Pellino, Cristina Cereda, Gianvincenzo Zuccotti. Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with ObesityChildren 2022; 9(8): 1174 doi: 10.3390/children9081174
327
Swati Singh, Anit Kumar, Suruchi Gupta, Rohini Agrawal. Curative role of natural PPARγ agonist in non-alcoholic fatty liver disease (NAFLD)Tissue Barriers 2023;  doi: 10.1080/21688370.2023.2289830
328
Maria Styliani Kalogirou, Olga Giouleme. Growing challenge of post-liver transplantation non-alcoholic fatty liver diseaseWorld Journal of Transplantation 2022; 12(9): 281-287 doi: 10.5500/wjt.v12.i9.281
329
Kavita Garg, Scott Brackett, Irl B. Hirsch, Satish K. Garg. NAFLD/NASH and DiabetesDiabetes Technology & Therapeutics 2020; 22(S1): S-174 doi: 10.1089/dia.2020.2513
330
Wanlu Su, Yuxia Wang, Kang Chen, Jie Wang, Anping Wang, Xulei Tang, Li Yan, Zuojie Luo, Guijun Qin, Lulu Chen, Guang Ning, Yiming Mu. Association between nonalcoholic fatty liver and increased low‐level albuminuria in postmenopausal women in China: A cross‐sectional studyJournal of Diabetes 2021; 13(6): 494 doi: 10.1111/1753-0407.13134
331
Feng-Zhi Xin, Ze-Hua Zhao, Rui-Nan Zhang, Qin Pan, Zi-Zhen Gong, Chao Sun, Jian-Gao Fan. Folic acid attenuates high-fat diet-induced steatohepatitis <i>via</i> deacetylase SIRT1-dependent restoration of PPARαWorld Journal of Gastroenterology 2020; 26(18): 2203-2220 doi: 10.3748/wjg.v26.i18.2203
332
L. B. Lazebnik, E. V. Golovanova, S. V. Turkina, K. L. Raikhelson, S. V. Okovityy, O. M. Drapkina, I. V. Maev, A. I. Martynov, G. E. Roitberg, O. V. Khlynova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, A. O. Bueverov, E. V. Vinitskaya, G. V. Volynets, E. Yu. Eremina, V. B. Grinevich, A. I. Dolgushina, A. N. Kazyulin, E. I. Kashkina, I. V. Kozlova, Yu. V. Konev, N. V. Korochanskaya, Yu. A. Kravchuk, E. D. Li, I. D. Loranskaya, V. M. Makhov, S. N. Mekhtiev, V. P. Novikova, O. D. Ostroumova, Ch. S. Pavlov, V. G. Radchenko, A. A. Samsonov, A. S. Sarsenbaeva, R. G. Sayfutdinov, P. V. Seliverstov, S. I. Sitkin, O. V. Stefanyuk, L. V. Tarasova, E. I. Tkachenko, Yu. P. Uspensky, Yu. A. Fominykh, A. I. Khavkin, Yu. V. Tsyganova, O. O. Sharhun. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third versionExperimental and Clinical Gastroenterology 2021; 1(1): 4 doi: 10.31146/1682-8658-ecg-185-1-4-52
333
Abdelilah Arredouani. Lifestyle-Related Diseases and Metabolic Syndrome2022;  doi: 10.5772/intechopen.106445
334
Michelle Saoi, Kazunori Sasaki, Hitoshi Sagawa, Kaori Abe, Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Yoshiaki Ohashi, Philip Britz-McKibbin. High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage PathwayJournal of Proteome Research 2020; 19(7): 2689 doi: 10.1021/acs.jproteome.9b00405
335
Elissa Lin, Aaron Justin Yeoh, Violeta Popov. Nutrition, Weight, and Digestive Health2022; : 207 doi: 10.1007/978-3-030-94953-2_13
336
Mykhailo Buchynskyi, Iryna Kamyshna, Valentyn Oksenych, Nataliia Zavidniuk, Aleksandr Kamyshnyi. The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current EvidenceViruses 2023; 15(5): 1072 doi: 10.3390/v15051072
337
Mohammad Yassin Zamanian, Mehraveh Sadeghi Ivraghi, Lusine G. Khachatryan, Diana E. Vadiyan, Hanie Yavarpour Bali, Maryam Golmohammadi. A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammationFood Science & Nutrition 2023; 11(12): 7485 doi: 10.1002/fsn3.3713
338
Yiling Qian, Yu Zhang, Xiaofang Fan, Hongmei Yan, Xuesong Li, Yujuan Fan, Yuping Song, Shuai Ma, Zheng Hu, Xin Gao, Jialin Yang. Nonalcoholic Fatty Liver Disease and Adverse Pregnancy Outcomes in Women With Normal Prepregnant WeightThe Journal of Clinical Endocrinology & Metabolism 2023; 108(2): 463 doi: 10.1210/clinem/dgac567
339
Amélio F. Godoy-Matos, Wellington S. Silva Júnior, Cynthia M. Valerio. NAFLD as a continuum: from obesity to metabolic syndrome and diabetesDiabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00570-y
340
Emily Brown, T. Hydes, A. Hamid, D.J. Cuthbertson. Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver DiseaseClinical Therapeutics 2021; 43(9): 1476 doi: 10.1016/j.clinthera.2021.07.013
341
Farqad Abdulqader, Lennex Yu, Mark H. Vickers, Elwyn C. Firth, Sue R. McGlashan. Voluntary physical activity in early life attenuates markers of fatty liver disease in adult male rats fed a high-fat dietBritish Journal of Nutrition 2023; 129(10): 1667 doi: 10.1017/S0007114522002562
342
Ja-Young Kwon. Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessmentClinical and Molecular Hepatology 2022; 28(1): 50 doi: 10.3350/cmh.2021.0359
343
Nick Finer. Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomesDiabetes, Obesity and Metabolism 2022; 24(S2): 44 doi: 10.1111/dom.14569
344
Shih-Chieh Shao, Liang-Tseng Kuo, Rong-Nan Chien, Ming-Jui Hung, Edward Chia-Cheng Lai. SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviewsBMJ Open Diabetes Research & Care 2020; 8(2): e001956 doi: 10.1136/bmjdrc-2020-001956
345
Kibo Nam, Mehnoosh Torkzaban, Dina Halegoua-DeMarzio, Corinne E Wessner, Andrej Lyshchik. Improving diagnostic accuracy of ultrasound texture features in detecting and quantifying hepatic steatosis using various beamforming sound speedsPhysics in Medicine & Biology 2023; 68(4): 04NT02 doi: 10.1088/1361-6560/acb635
346
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive ApproachesDiagnostics 2022; 12(2): 407 doi: 10.3390/diagnostics12020407
347
Jae Young Choi, Tae-Woo Jang, Phil Hyun Song, Seong Hoon Choi, Sae-Kwang Ku, Chang-Hyun Song. Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in MiceAntioxidants 2022; 11(3): 580 doi: 10.3390/antiox11030580
348
Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, Katrin Bose, Peter R. Mertens, Christos Chatzikyrkou. Association of metabolic syndrome and chronic kidney diseaseObesity Reviews 2024; 25(1) doi: 10.1111/obr.13649
349
Sara Armani, Andreas Geier, Thomas Forst, Uta Merle, David H. Alpers, Martin W. Lunnon. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactionsBritish Journal of Clinical Pharmacology 2024; 90(4): 942 doi: 10.1111/bcp.15990
350
Elaheh Zarean, Mehdi Azizmohammad Looha, Payam Amini, Ali Ahmadi, Pierre-Antoine Dugué. Sleep characteristics of middle-aged adults with non-alcoholic fatty liver disease: findings from the Shahrekord PERSIAN cohort studyBMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-15251-4
351
Mohammad Bagher Majnooni, Mari Ataee, Gholamreza Bahrami, Fatemeh Heydarpour, Ina Yosifova Aneva, Mohammad Hosein Farzaei, Touraj Ahmadi‐Juoibari. The effects of co‐administration of artichoke leaf extract supplementation with metformin and vitamin E in patients with nonalcoholic fatty liver disease: A randomized clinical trialPhytotherapy Research 2021; 35(11): 6324 doi: 10.1002/ptr.7279
352
Roberta Rinaldi, Sara De Nucci, Fabio Castellana, Martina Di Chito, Vito Giannuzzi, Endrit Shahini, Roberta Zupo, Luisa Lampignano, Giuseppina Piazzolla, Vincenzo Triggiani, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. The Effects of Eight Weeks’ Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and ObesityNutrients 2023; 15(4): 825 doi: 10.3390/nu15040825
353
Dariusz Narankiewicz, Josefina Ruiz-Nava, Veronica Buonaiuto, María Isabel Ruiz-Moreno, María Dolores López-Carmona, Luis Miguel Pérez-Belmonte, Ricardo Gómez-Huelgas, María Rosa Bernal-López. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean PopulationInternational Journal of Environmental Research and Public Health 2020; 17(10): 3518 doi: 10.3390/ijerph17103518
354
Véronique Cheff, Mayra Trentin-Sonoda, Amélie Blais, Jean-François Thibodeau, Chet E. Holterman, Alex Gutsol, Christopher R. J. Kennedy, Richard L. Hébert, Michael W. Greene. High fat diet is protective against kidney injury in hypertensive-diabetic mice, but leads to liver injuryPLOS ONE 2023; 18(2): e0281123 doi: 10.1371/journal.pone.0281123
355
David S. Mathiesen, Asger Lund, Tina Vilsbøll, Filip K. Knop, Jonatan I. Bagger. Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver FatFrontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.617400
356
Laura Antonucci, Cristiana Porcu, Eleonora Timperi, Silvano Junior Santini, Gino Iannucci, Clara Balsano. Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes ActivityJournal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/4570219
357
Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver DiseaseCancers 2021; 13(4): 790 doi: 10.3390/cancers13040790